Datasets:
hasnat79
/
pubmed25_cardio

Dataset card Data Studio Files
xet
 Community
1
PMID
int64
157
39.8M
PMID_Version
int64
1
3
Title
stringlengths
1
794
⌀
Status
stringclasses
2 values
IndexingMethod
stringclasses
4 values
Owner
stringclasses
6 values
Abstract
stringlengths
1
9.97k
Journal_Title
stringlengths
2
239
ISSN
stringlengths
9
9
⌀
ISSN_Type
stringclasses
2 values
Volume
stringlengths
1
161
⌀
Issue
stringlengths
1
75
⌀
CitedMedium
stringclasses
2 values
PubDate_Year
float64
1.95k
2.03k
⌀
PubDate_Month
stringclasses
24 values
PubDate_Day
float64
1
31
⌀
Pagination
stringlengths
1
51
⌀
Authors
stringlengths
8
10.1k
⌀
PublicationTypes
stringlengths
14
320
Chemicals
stringlengths
30
2k
⌀
MeSHHeadings_Full
stringlengths
65
4.49k
MeSH_Descriptors
stringlengths
6
910
MeSH_Qualifiers
stringlengths
1
1.11k
MeSH_MajorTopics
stringlengths
1
93
Grants
stringlengths
15
18k
⌀
DateCompleted
stringlengths
10
10
DateRevised
stringlengths
10
10
PublicationHistory
stringlengths
57
214
ArticleIDs
stringlengths
10
222
category
stringclasses
7 values
sub_category
stringlengths
2
232
18,682
1
The scientific foundations of clinical enzymology.
MEDLINE
Manual
NLM
Clinical enzymology is the study of the activity and properties of enzymes in specimens (usually of blood) taken from patients, as an aid to the diagnosis and understanding of disease. Research in many areas of enzymology is undertaken to strengthen the foundations on which the clinical interpretation of such enzyme me...
Die Naturwissenschaften
0028-1042
Print
64
5
Print
1,977
May
null
253-9
D W Moss (DW)
Journal Article (D016428); Review (D016454)
Enzymes (Registry: 0, UI: D004798); Isoenzymes (Registry: 0, UI: D007527); L-Lactate Dehydrogenase (Registry: EC 1.1.1.27, UI: D007770); Aspartate Aminotransferases (Registry: EC 2.6.1.1, UI: D001219); Creatine Kinase (Registry: EC 2.7.3.2, UI: D003402); Alkaline Phosphatase (Registry: EC 3.1.3.1, UI: D000469); gamma-G...
Alkaline Phosphatase (UI: D000469, Major: No) - Qualifiers: metabolism (UI: Q000378, Major: No); Aspartate Aminotransferases (UI: D001219, Major: No) - Qualifiers: blood (UI: Q000097, Major: No); Cholestasis (UI: D002779, Major: No) - Qualifiers: enzymology (UI: Q000201, Major: No); Creatine Kinase (UI: D003402, Major:...
Alkaline Phosphatase|Aspartate Aminotransferases|Cholestasis|Creatine Kinase|Enzymes|Humans|Isoenzymes|L-Lactate Dehydrogenase|Liver|Myocardial Infarction|Myocardium|gamma-Glutamylcyclotransferase
metabolism (0)|blood (0)|enzymology (0)|blood (0)|blood (0); metabolism (1)||blood (0)|blood (0)|enzymology (0)|enzymology (0)|enzymology (0)|metabolism (0)
0|0|0|0|0|0|0|0|0|0|0|0
null
1977-09-17
2019-12-10
pubmed: 1977-5-1; medline: 1977-5-1 0:1; entrez: 1977-5-1 0:0
pubmed: 324243; doi: 10.1007/BF00438297
Myocardial Ischemia
['Myocardial Infarction']
18,964
1
[Use of sodium nitroprusside in cardiology].
MEDLINE
Manual
NLM
Sodium nitroprusside (SNP) is rarely used in cardiology. It is reserved traditionally for severe episodes of arterial hypertension. Certain states of refractory heart failure represent new indications for use, which implies a double haemodynamic monitoring system: continuous control of systemic blood pressure by intra-...
Annales de l'anesthesiologie francaise
0003-4061
Print
18
2
Print
1,977
null
null
179-85
J A Trigano (JA); A Saadjian (A); G Nava (G); J Torresani (J); A Jouve (A)
English Abstract (D004740); Journal Article (D016428)
Ferricyanides (Registry: 0, UI: D005292); Nitroprusside (Registry: 169D1260KM, UI: D009599)
Adult (UI: D000328, Major: No); Arterial Occlusive Diseases (UI: D001157, Major: No) - Qualifiers: drug therapy (UI: Q000188, Major: Yes); Female (UI: D005260, Major: No); Ferricyanides (UI: D005292, Major: No) - Qualifiers: therapeutic use (UI: Q000627, Major: Yes); Heart Failure (UI: D006333, Major: No) - Qualifiers:...
Adult|Arterial Occlusive Diseases|Female|Ferricyanides|Heart Failure|Hemodynamics|Humans|Hypertension|Hypotension, Controlled|Male|Middle Aged|Nitroprusside|Shock, Cardiogenic
|drug therapy (1)||therapeutic use (1)|drug therapy (1)|drug effects (0)||drug therapy (1)||||therapeutic use (1)|drug therapy (1)
0|0|0|0|0|0|0|0|1|0|0|0|0
null
1977-09-17
2013-11-21
pubmed: 1977-1-1; medline: 1977-1-1 0:1; entrez: 1977-1-1 0:0
pubmed: 18964
Heart Failure
[]
19,114
1
Prophylactiv use of propranolol in the Marfan syndrome to prevent aortic dissection.
MEDLINE
Manual
NLM
Twenty-five patients, 16 men and 9 women, 5-59 years of age with the Marfan syndrome and cardiac complications were started on propranolol over a 6-year period. Propranolol was used as a beta-adrenergic blocking agent to reduce myocardial contractility in an attempt thereby to stay the progression of aortic dilatation ...
Birth defects original article series
0547-6844
Print
13
3C
Print
1,977
null
null
163-9
L Ose (L); V A McKusick (VA)
Journal Article (D016428); Research Support, U.S. Gov't, P.H.S. (D013487)
Adrenergic beta-Antagonists (Registry: 0, UI: D000319); Propranolol (Registry: 9Y8NXQ24VQ, UI: D011433)
Adolescent (UI: D000293, Major: No); Adrenergic beta-Antagonists (UI: D000319, Major: No) - Qualifiers: therapeutic use (UI: Q000627, Major: No); Adult (UI: D000328, Major: No); Aorta, Thoracic (UI: D001013, Major: No); Aortic Aneurysm (UI: D001014, Major: No) - Qualifiers: etiology (UI: Q000209, Major: No); prevention...
Adolescent|Adrenergic beta-Antagonists|Adult|Aorta, Thoracic|Aortic Aneurysm|Child, Preschool|Female|Humans|Male|Marfan Syndrome|Myocardial Contraction|Propranolol|Pulse
|therapeutic use (0)|||etiology (0); prevention & control (1)|||||complications (1); drug therapy (0)|drug effects (0)|therapeutic use (1)|drug effects (0)
0|0|0|0|0|0|0|0|0|0|0|0|0
null
1977-10-14
2013-11-21
pubmed: 1977-1-1; medline: 1977-1-1 0:1; entrez: 1977-1-1 0:0
pubmed: 19114
Heart Defects, Congenital
['Marfan Syndrome']
19,122
1
Increased exercise tolerance with nitrates in beta-blockaded patients with angina.
MEDLINE
Manual
NLM
In 14 beta-blockaded anginal subjects, 10 of whom had poor left ventricular function, sublingual isosorbide dinitrate significantly increased maximal exercise capacity on a standardized multistage treadmill test. This was associated with changes in heart rate and blood pressure suggestive of a fall in left ventricular ...
British medical journal
0007-1447
Print
2
6086
Print
1,977
Aug
27
550-2
R H Baxter (RH); I M Lennox (IM)
Journal Article (D016428)
Adrenergic beta-Antagonists (Registry: 0, UI: D000319); Isosorbide Dinitrate (Registry: IA7306519N, UI: D007548)
Adrenergic beta-Antagonists (UI: D000319, Major: No) - Qualifiers: therapeutic use (UI: Q000627, Major: Yes); Adult (UI: D000328, Major: No); Angina Pectoris (UI: D000787, Major: No) - Qualifiers: drug therapy (UI: Q000188, Major: Yes); Blood Pressure (UI: D001794, Major: No) - Qualifiers: drug effects (UI: Q000187, Ma...
Adrenergic beta-Antagonists|Adult|Angina Pectoris|Blood Pressure|Drug Therapy, Combination|Heart Rate|Humans|Isosorbide Dinitrate|Male|Middle Aged|Physical Exertion
therapeutic use (1)||drug therapy (1)|drug effects (0)||drug effects (0)||pharmacology (0); therapeutic use (1)|||drug effects (1)
0|0|0|0|0|0|0|0|0|0|0
null
1977-10-20
2019-05-01
pubmed: 1977-8-27; medline: 1977-8-27 0:1; entrez: 1977-8-27 0:0
pubmed: 4975605; pmc: PMC1631445; doi: 10.1136/bmj.2.6086.550
Myocardial Ischemia
['Angina Pectoris']
20,005
1
[Action of dibencozide on nitrogen metabolism in immediate and long-term postoperative resuscitation].
MEDLINE
Manual
NLM
The catabolic orientation of the immediate post-aggression phase is aggravated in neurosurgery by the almost routine prescription of corticosteroids. This emphasises the value of any treatment which might limit this orientation. The authors report their experience with the use of dibencozide, with its known facilitatin...
Annales de l'anesthesiologie francaise
0003-4061
Print
18
3
Print
1,977
Jul
19
275-84
B Roquefeuil (B); E Escuret (E); M P Duboin (MP)
Clinical Trial (D016430); Controlled Clinical Trial (D018848); English Abstract (D004740); Journal Article (D016428)
Cobamides (Registry: 0, UI: D003038); Electrolytes (Registry: 0, UI: D004573); Nitrogen (Registry: N762921K75, UI: D009584)
Adult (UI: D000328, Major: No); Brain Injuries (UI: D001930, Major: No) - Qualifiers: surgery (UI: Q000601, Major: No); Brain Neoplasms (UI: D001932, Major: No) - Qualifiers: surgery (UI: Q000601, Major: No); Cerebrovascular Disorders (UI: D002561, Major: No) - Qualifiers: surgery (UI: Q000601, Major: No); Cobamides (U...
Adult|Brain Injuries|Brain Neoplasms|Cerebrovascular Disorders|Cobamides|Electrolytes|Female|Humans|Male|Middle Aged|Neurosurgery|Nitrogen|Parenteral Nutrition|Postoperative Care
|surgery (0)|surgery (0)|surgery (0)|therapeutic use (1)|metabolism (0)||||||metabolism (1)||
0|0|0|0|0|0|0|0|0|0|1|0|0|1
null
1977-10-14
2013-11-21
pubmed: 1977-7-19; medline: 1977-7-19 0:1; entrez: 1977-7-19 0:0
pubmed: 20005
Cerebrovascular Disorders
['Cerebrovascular Disorders']
20,010
1
[Atypical pulmonary embolism associated with inter-auricular communication].
MEDLINE
Manual
NLM
A case of massive pulmonary embolism at a patient with undetected atrial defect is reported. The authors discuss the difficulties of establishing a proper diagnosis when the right heart pressure is not raised and when a large emboliser is well tolerated. Angiography confirmed the diagnosis and the patient was successfu...
Annales de l'anesthesiologie francaise
0003-4061
Print
18
3
Print
1,977
Jul
19
309-12
J du Cailar (J); P A Chaptal (PA); F d'Athis (F); J Kienlen (J); F Lauret (F)
Case Reports (D002363); English Abstract (D004740); Journal Article (D016428)
null
Heart Septal Defects, Atrial (UI: D006344, Major: No) - Qualifiers: complications (UI: Q000150, Major: Yes); diagnosis (UI: Q000175, Major: No); Humans (UI: D006801, Major: No); Male (UI: D008297, Major: No); Middle Aged (UI: D008875, Major: No); Pulmonary Embolism (UI: D011655, Major: No) - Qualifiers: diagnosis (UI: ...
Heart Septal Defects, Atrial|Humans|Male|Middle Aged|Pulmonary Embolism
complications (1); diagnosis (0)||||diagnosis (1); etiology (0)
0|0|0|0|0
null
1977-10-14
2006-11-15
pubmed: 1977-7-19; medline: 1977-7-19 0:1; entrez: 1977-7-19 0:0
pubmed: 20010
Heart Defects, Congenital
['Heart Septal Defects']
20,011
1
[The cerebro-cardiac syndrome in neuro-traumatology].
MEDLINE
Manual
NLM
Head trauma is a possible cause of E.C.G. modifications originating in the brain and unresponsive to pure symptomatic cardial therapy. On the other hand, these perturbations react in a favourable way to treatment aimed at protecting the heart against descending nociceptive influx caused by brain injury. This report sho...
Annales de l'anesthesiologie francaise
0003-4061
Print
18
3
Print
1,977
Jul
19
313-9
E Mouawad (E); J Berre (J)
Case Reports (D002363); English Abstract (D004740); Journal Article (D016428)
null
Adolescent (UI: D000293, Major: No); Adult (UI: D000328, Major: No); Arrhythmias, Cardiac (UI: D001145, Major: No) - Qualifiers: etiology (UI: Q000209, Major: Yes); Brain Injuries (UI: D001930, Major: No) - Qualifiers: complications (UI: Q000150, Major: Yes); Coma (UI: D003128, Major: No) - Qualifiers: complications (U...
Adolescent|Adult|Arrhythmias, Cardiac|Brain Injuries|Coma|Contusions|Craniocerebral Trauma|Humans|Male
||etiology (1)|complications (1)|complications (0)|complications (1)|complications (0)||
0|0|0|0|0|0|0|0|0
null
1977-10-14
2007-11-15
pubmed: 1977-7-19; medline: 1977-7-19 0:1; entrez: 1977-7-19 0:0
pubmed: 20011
Arrhythmias, Cardiac
[]
20,348
1
Fetal heart rate response to maternal hypotension during amniocentesis.
MEDLINE
Manual
NLM
Ten cases of severe fetal heart rate deceleration following maternal vaso-vagal reflex during amniocentesis were presented. The good outcome of these fetuses suggests that this transient phenomenon has no adverse effect on the fetus. This type of FHR response should be recognized so as to avoid unnecessary Caesarian se...
International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics
0020-7292
Print
14
6
Print
1,976
null
null
503-4
M Ron (M); H Yaffe (H); W Z Polishuk (WZ)
Journal Article (D016428)
null
Amniocentesis (UI: D000649, Major: Yes) - Qualifiers: adverse effects (UI: Q000009, Major: No); Bradycardia (UI: D001919, Major: No) - Qualifiers: etiology (UI: Q000209, Major: No); Female (UI: D005260, Major: No); Fetal Heart (UI: D005318, Major: No) - Qualifiers: physiology (UI: Q000502, Major: Yes); Heart Rate (UI: ...
Amniocentesis|Bradycardia|Female|Fetal Heart|Heart Rate|Humans|Hypotension|Pregnancy
adverse effects (0)|etiology (0)||physiology (1)|||etiology (1)|
1|0|0|0|1|0|0|0
null
1977-11-25
2019-08-19
pubmed: 1976-1-1; medline: 1976-1-1 0:1; entrez: 1976-1-1 0:0
pubmed: 20348; doi: 10.1002/j.1879-3479.1976.tb00094.x
Arrhythmias, Cardiac
['Bradycardia']
20,396
1
[Comparative study between dobutamine and other catecholamines in their effects on the cardiac contraction and rhythm (author's transl)].
MEDLINE
Manual
NLM
Dobutamine (DOB) showed a dose dependent positive introphic effect on the right ventricular muscle of vagotomized Beagle dogs under pentobarbital anesthesia. Positve inotropic effects of other catecholamines (CA) decreased in the following order; isoproterenol (Iso, 115) greater than norepinephrine (NE, 15) greater tha...
Nihon yakurigaku zasshi. Folia pharmacologica Japonica
0015-5691
Print
73
4
Print
1,977
May
null
501-16
M Ueda (M); S Matsumura (S); S Matsuda (S); M Kawakami (M); E Morishige (E)
Comparative Study (D003160); English Abstract (D004740); Journal Article (D016428)
Adrenergic alpha-Antagonists (Registry: 0, UI: D000317); Adrenergic beta-Antagonists (Registry: 0, UI: D000319); Catecholamines (Registry: 0, UI: D002395); Phenoxybenzamine (Registry: 0TTZ664R7Z, UI: D010643); Dobutamine (Registry: 3S12J47372, UI: D004280); Propranolol (Registry: 9Y8NXQ24VQ, UI: D011433); Isoproterenol...
Adrenergic alpha-Antagonists (UI: D000317, Major: No) - Qualifiers: pharmacology (UI: Q000494, Major: No); Adrenergic beta-Antagonists (UI: D000319, Major: No) - Qualifiers: pharmacology (UI: Q000494, Major: No); Animals (UI: D000818, Major: No); Arrhythmias, Cardiac (UI: D001145, Major: No) - Qualifiers: chemically in...
Adrenergic alpha-Antagonists|Adrenergic beta-Antagonists|Animals|Arrhythmias, Cardiac|Cardiovascular System|Catecholamines|Cats|Depression, Chemical|Dobutamine|Dogs|Dopamine|Dose-Response Relationship, Drug|Female|Heart Rate|In Vitro Techniques|Isoproterenol|Ligation|Male|Myocardial Contraction|Norepinephrine|Papillary...
pharmacology (0)|pharmacology (0)||chemically induced (0)|drug effects (0)|pharmacology (1)|||pharmacology (1)||pharmacology (0)|||drug effects (1)||pharmacology (0)|||drug effects (1)|pharmacology (0)|drug effects (0)|pharmacology (0)|pharmacology (0)||
0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0
null
1977-11-30
2019-08-27
pubmed: 1977-5-1; medline: 1977-5-1 0:1; entrez: 1977-5-1 0:0
pubmed: 20396; doi: 10.1254/fpj.73.501
Arrhythmias, Cardiac
[]
20,398
1
[Clinical picture of lactate acidosis. 4: Clinical significance of lactate acidosis].
MEDLINE
Manual
NLM
The diagnosis of lactate acidosis is complicated by the fact that lactate determination is not a routine method in clinical chemistry. In fact, lactate analysis is performed only in special laboratories. Even in greater clinics this method is not routinely performed in differential diagnosis of acidotic states. Various...
Fortschritte der Medizin
0015-8178
Print
95
34
Print
1,977
Sep
15
2095-7
H Förster (H)
English Abstract (D004740); Journal Article (D016428)
Lactates (Registry: 0, UI: D007773)
Acidosis (UI: D000138, Major: No) - Qualifiers: blood (UI: Q000097, Major: No); diagnosis (UI: Q000175, Major: Yes); etiology (UI: Q000209, Major: No); Heart Failure (UI: D006333, Major: No) - Qualifiers: complications (UI: Q000150, Major: No); Humans (UI: D006801, Major: No); Hydrogen-Ion Concentration (UI: D006863, M...
Acidosis|Heart Failure|Humans|Hydrogen-Ion Concentration|Lactates|Pancreatitis|Shock, Septic
blood (0); diagnosis (1); etiology (0)|complications (0)|||blood (1)|complications (0)|complications (0)
0|0|0|0|0|0|0
null
1977-11-25
2007-11-15
pubmed: 1977-9-15; medline: 1977-9-15 0:1; entrez: 1977-9-15 0:0
pubmed: 20398
Heart Failure
[]
20,519
1
The medical management of angina pectoris.
MEDLINE
Manual
NLM
The availability of excellent short-acting and long-acting drugs for the treatment of angina pectoris needs to be emphasized. Properly used in conjunction with other measures such as the treatment of hypertension and a graded exercise routine, they provide, for most patients with angina, a tested therapeutic program th...
JAMA
0098-7484
Print
238
17
Print
1,977
Oct
24
1847-8
O Paul (O)
Journal Article (D016428)
Adrenergic beta-Antagonists (Registry: 0, UI: D000319); Delayed-Action Preparations (Registry: 0, UI: D003692); Amyl Nitrite (Registry: 8017-89-8, UI: D000680); Nitroglycerin (Registry: G59M7S0WS3, UI: D005996); Isosorbide Dinitrate (Registry: IA7306519N, UI: D007548)
Adrenergic beta-Antagonists (UI: D000319, Major: No) - Qualifiers: therapeutic use (UI: Q000627, Major: No); Amyl Nitrite (UI: D000680, Major: No) - Qualifiers: therapeutic use (UI: Q000627, Major: No); Angina Pectoris (UI: D000787, Major: No) - Qualifiers: drug therapy (UI: Q000188, Major: Yes); prevention & control (...
Adrenergic beta-Antagonists|Amyl Nitrite|Angina Pectoris|Delayed-Action Preparations|Humans|Isosorbide Dinitrate|Nitroglycerin|Posture
therapeutic use (0)|therapeutic use (0)|drug therapy (1); prevention & control (0)|||therapeutic use (0)|therapeutic use (0)|
0|0|0|0|0|0|0|0
null
1977-11-30
2016-10-17
pubmed: 1977-10-24; medline: 1977-10-24 0:1; entrez: 1977-10-24 0:0
pubmed: 20519
Myocardial Ischemia
['Angina Pectoris']
20,557
1
Adverse reactions after smallpox vaccination.
MEDLINE
Manual
NLM
Nine hundred and thirty-eight reports of adverse reactions of smallpox vaccination in Australia between 1960 and 1976 have been analysed according to the type of reaction, and the age and sex of vaccinee. In an estimated 5,000,000 vaccinations, the reaction rate was 188/million, and the death rate 1-5/million. Generali...
The Medical journal of Australia
0025-729X
Print
2
6
Print
1,977
Aug
6
180-3
B J Feery (BJ)
Journal Article (D016428)
Immunoglobulins (Registry: 0, UI: D007136); Smallpox Vaccine (Registry: 0, UI: D012900)
Adolescent (UI: D000293, Major: No); Adult (UI: D000328, Major: No); Age Factors (UI: D000367, Major: No); Aged (UI: D000368, Major: No); Australia (UI: D001315, Major: No); Child (UI: D002648, Major: No); Child, Preschool (UI: D002675, Major: No); Encephalomyelitis, Acute Disseminated (UI: D004673, Major: No) - Qualif...
Adolescent|Adult|Age Factors|Aged|Australia|Child|Child, Preschool|Encephalomyelitis, Acute Disseminated|Female|Humans|Immunoglobulins|Infant|Infant, Newborn|Male|Middle Aged|Myocarditis|Pericarditis|Sex Factors|Smallpox|Smallpox Vaccine|Vaccination|Vaccinia
|||||||epidemiology (0)|||therapeutic use (0)|||||epidemiology (0)|epidemiology (0)||prevention & control (1)|adverse effects (1)|adverse effects (1); mortality (0)|epidemiology (0)
0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0
null
1977-11-25
2021-03-13
pubmed: 1977-8-6; medline: 1977-8-6 0:1; entrez: 1977-8-6 0:0
pubmed: 20557; doi: 10.5694/j.1326-5377.1977.tb114544.x
Cardiomyopathies
['Myocarditis']
20,802
1
[Importance of space analysis of U-moment-vectors concerning ageing people and chronical heart and blood circulation diseases (author's transl)].
MEDLINE
Manual
NLM
U-vectors are a stabil component of electric activity of the heart repolarisation. The examinations of the space sizes and direction of the U-moment-vectors give an idea about the character of repolarisation of Purkinje's fibres and papillar muscles in old age and in chronical heart and blood circulation diseases. Path...
Aktuelle Gerontologie
0300-5704
Print
7
8
Print
1,977
Aug
null
421-6
B Zdichynec (B)
English Abstract (D004740); Journal Article (D016428)
null
Adult (UI: D000328, Major: No); Aged (UI: D000368, Major: No); Aging (UI: D000375, Major: Yes); Aortic Valve Stenosis (UI: D001024, Major: No) - Qualifiers: physiopathology (UI: Q000503, Major: No); Cardiovascular Diseases (UI: D002318, Major: No) - Qualifiers: physiopathology (UI: Q000503, Major: Yes); Chronic Disease...
Adult|Aged|Aging|Aortic Valve Stenosis|Cardiovascular Diseases|Chronic Disease|Humans|Hypertension|Middle Aged|Mitral Valve Insufficiency|Mitral Valve Stenosis
|||physiopathology (0)|physiopathology (1)|||physiopathology (0)||physiopathology (0)|physiopathology (0)
0|0|1|0|0|0|0|0|0|0|0
null
1977-11-25
2006-11-15
pubmed: 1977-8-1; medline: 1977-8-1 0:1; entrez: 1977-8-1 0:0
pubmed: 20802
Heart Valve Diseases
['Aortic Valve Stenosis', 'Mitral Valve Insufficiency', 'Mitral Valve Stenosis']
21,032
1
Left internal mammary--left ventricular fistula after Vineberg operation.
MEDLINE
Manual
NLM
This communication presents an unusual complication in a patient who underwent the Vineberg procedure with the formation of an internal mammary to left-ventricular fistula, which caused a new apical diastolic murmur. This represents a previously unreported etiology for the appearance of an apical blowing diastolic murm...
Catheterization and cardiovascular diagnosis
0098-6569
Print
3
3
Print
1,977
null
null
279-82
I Kronzon (I); M Schloss (M); E Glassman (E)
Case Reports (D002363); Journal Article (D016428)
null
Coronary Disease (UI: D003327, Major: No) - Qualifiers: surgery (UI: Q000601, Major: Yes); Fistula (UI: D005402, Major: No) - Qualifiers: etiology (UI: Q000209, Major: Yes); Heart Diseases (UI: D006331, Major: No) - Qualifiers: etiology (UI: Q000209, Major: Yes); Heart Ventricles (UI: D006352, Major: Yes); Humans (UI: ...
Coronary Disease|Fistula|Heart Diseases|Heart Ventricles|Humans|Male|Mammary Arteries|Middle Aged|Myocardial Revascularization|Thoracic Arteries
surgery (1)|etiology (1)|etiology (1)||||||adverse effects (1)|
0|0|0|1|0|0|1|0|0|1
null
1977-12-29
2019-08-27
pubmed: 1977-1-1; medline: 1977-1-1 0:1; entrez: 1977-1-1 0:0
pubmed: 21032; doi: 10.1002/ccd.1810030311
Myocardial Ischemia
['Coronary Disease']
21,323
1
[Prostaglandin E1: effect on blood gases in infants with cyanotic congenital heart disease (author's transl)].
MEDLINE
Manual
NLM
15 infants with cyanotic congenital heart disease (pulmonary atresia, Ebstein-Syndrom) were treated with Prostaglandin E1. During treatment there was a significant rise of PO2 and SO2 in the arterial, capillary and central venous blood. There was a minor rise of pH and HCO3; the arterial pCO2 fell slightly. We used PGE...
Klinische Padiatrie
0300-8630
Print
189
5
Print
1,977
Sep
null
365-9
J G Schöber (JG); M Kellner (M); I Christian (I)
English Abstract (D004740); Journal Article (D016428)
Bicarbonates (Registry: 0, UI: D001639); Prostaglandins E (Registry: 0, UI: D011458); Carbon Dioxide (Registry: 142M471B3J, UI: D002245); Oxygen (Registry: S88TT14065, UI: D010100)
Bicarbonates (UI: D001639, Major: No) - Qualifiers: blood (UI: Q000097, Major: No); Blood (UI: D001769, Major: No); Blood Gas Analysis (UI: D001784, Major: Yes); Carbon Dioxide (UI: D002245, Major: No) - Qualifiers: blood (UI: Q000097, Major: No); Female (UI: D005260, Major: No); Heart Defects, Congenital (UI: D006330,...
Bicarbonates|Blood|Blood Gas Analysis|Carbon Dioxide|Female|Heart Defects, Congenital|Humans|Hydrogen-Ion Concentration|Infant|Infant, Newborn|Male|Oxygen|Partial Pressure|Preoperative Care|Prostaglandins E|Pulmonary Valve
blood (0)|||blood (0)||surgery (0)||||||blood (0)|||adverse effects (0); pharmacology (1)|abnormalities (0)
0|0|1|0|0|0|0|0|0|0|0|0|0|0|0|0
null
1977-12-29
2013-11-21
pubmed: 1977-9-1; medline: 1977-9-1 0:1; entrez: 1977-9-1 0:0
pubmed: 21323
Heart Defects, Congenital
[]
21,372
1
Comparative study of beta andreoceptor antagonists on the isolated atria of control and of the reserpine treated rabbits.
MEDLINE
Manual
NLM
The effect of four adrenoceptor antagonists, chosen because of reported differences in their selectivities, were compared using the positive chronotropic response to isoprenaline on isolated rabbit atria. Oxprenolol was the most potent antagonist of the isoprenaline induced cardiac arrhythmias. Alprenolol, practolol an...
Pahlavi medical journal
0030-9427
Print
8
3
Print
1,977
Jul
null
326-44
M A Hague (MA); M K Darabi (MK); M R Khalighi (MR)
Comparative Study (D003160); Journal Article (D016428)
Adrenergic beta-Antagonists (Registry: 0, UI: D000319); Oxprenolol (Registry: 519MXN9YZR, UI: D010096); Alprenolol (Registry: 877K5MQ27W, UI: D000526); Reserpine (Registry: 8B1QWR724A, UI: D012110); Propranolol (Registry: 9Y8NXQ24VQ, UI: D011433); Isoproterenol (Registry: L628TT009W, UI: D007545); Practolol (Registry: ...
Adrenergic beta-Antagonists (UI: D000319, Major: No) - Qualifiers: pharmacology (UI: Q000494, Major: Yes); Alprenolol (UI: D000526, Major: No) - Qualifiers: pharmacology (UI: Q000494, Major: No); Animals (UI: D000818, Major: No); Arrhythmias, Cardiac (UI: D001145, Major: No) - Qualifiers: chemically induced (UI: Q00013...
Adrenergic beta-Antagonists|Alprenolol|Animals|Arrhythmias, Cardiac|Female|Heart Atria|Heart Rate|Isoproterenol|Male|Oxprenolol|Practolol|Propranolol|Rabbits|Reserpine
pharmacology (1)|pharmacology (0)||chemically induced (0)||drug effects (1)|drug effects (0)|antagonists & inhibitors (0); pharmacology (0)||pharmacology (0)|pharmacology (0)|pharmacology (0)||pharmacology (1)
0|0|0|0|0|0|0|0|0|0|0|0|0|0
null
1977-12-29
2013-11-21
pubmed: 1977-7-1; medline: 1977-7-1 0:1; entrez: 1977-7-1 0:0
pubmed: 21372
Arrhythmias, Cardiac
[]
21,455
1
Repeat myocardial revascularization for uncontrollable angina after occlusion of prior aortocoronary bypass.
MEDLINE
Manual
NLM
Twelve patients at Emory University Hospital have had repeat myocardial revascularization for recurrent, uncontrollable, disabling angina pectoris after previous coronary artery bypass grafts. The interval betweeen initial bypass procedure and reoperation ranged from six weeks to six years. The native coronary circulat...
Southern medical journal
0038-4348
Print
70
11
Print
1,977
Nov
null
1317-9
J M Craver (JM); E L Jones (EL); A B Sams (AB); C R Hatcher (CR)
Journal Article (D016428)
null
Adult (UI: D000328, Major: No); Angina Pectoris (UI: D000787, Major: No) - Qualifiers: diagnostic imaging (UI: Q000000981, Major: No); surgery (UI: Q000601, Major: Yes); Coronary Angiography (UI: D017023, Major: No); Coronary Artery Bypass (UI: D001026, Major: Yes); Female (UI: D005260, Major: No); Follow-Up Studies (U...
Adult|Angina Pectoris|Coronary Angiography|Coronary Artery Bypass|Female|Follow-Up Studies|Humans|Male|Middle Aged|Myocardial Revascularization|Postoperative Complications|Recurrence|Saphenous Vein|Transplantation, Autologous
|diagnostic imaging (0); surgery (1)|||||||||diagnostic imaging (0); surgery (1)||transplantation (0)|
0|0|0|1|0|0|0|0|0|0|0|0|0|0
null
1977-12-29
2019-07-02
pubmed: 1977-11-1; medline: 2001-3-28 10:1; entrez: 1977-11-1 0:0
pubmed: 21455; doi: 10.1097/00007611-197711000-00022
Myocardial Ischemia
['Angina Pectoris']
21,481
1
Splenic-gonadal fusion and adrenal cortical rest associated with bilateral cryptorchism.
MEDLINE
Manual
NLM
A patient with bilateral cryptorchism had ectopic splenic tissue adherent to his left testicle and an adrenal cortical rest adherent to his right testicle. The embrylogic basis for these disorders is discussed and the literature reviewed.
Urology
0090-4295
Print
10
4
Print
1,977
Oct
null
337-40
A E Finkbeiner (AE); P A DeRidder (PA); S E Ryden (SE)
Case Reports (D002363); Journal Article (D016428)
null
Adrenal Cortex (UI: D000302, Major: No) - Qualifiers: abnormalities (UI: Q000002, Major: Yes); pathology (UI: Q000473, Major: No); Child, Preschool (UI: D002675, Major: No); Cryptorchidism (UI: D003456, Major: No) - Qualifiers: complications (UI: Q000150, Major: Yes); pathology (UI: Q000473, Major: No); Heart Septal De...
Adrenal Cortex|Child, Preschool|Cryptorchidism|Heart Septal Defects, Ventricular|Humans|Male|Spleen|Testis
abnormalities (1); pathology (0)||complications (1); pathology (0)|complications (0)|||abnormalities (1); pathology (0)|abnormalities (1); pathology (0)
0|0|0|0|0|0|0|0
null
1977-12-29
2019-07-13
pubmed: 1977-10-1; medline: 1977-10-1 0:1; entrez: 1977-10-1 0:0
pubmed: 21481; doi: 10.1016/0090-4295(77)90163-7
Heart Defects, Congenital
['Heart Septal Defects']
21,758
1
A possible change in the rate-limiting step for cardiac norepinephrine synthesis in the cardiomyopathic Syrian hamster.
MEDLINE
Manual
NLM
The development of heart failure in the cardiomyopathic hamster is associated with a decrease in norepinephrine stores and parallel increases in cardiac sympathetic tone and tyrosine hydroxylase activity. Despite the increase in tyrosine hydroxylase, cardiac norepinephrine synthesis does not increase in heart failure. ...
Circulation research
0009-7330
Print
41
6
Print
1,977
Dec
null
814-7
M J Sole (MJ); A B Kamble (AB); M N Hussain (MN)
Journal Article (D016428); Research Support, U.S. Gov't, P.H.S. (D013487)
Catecholamines (Registry: 0, UI: D002395); Tyrosine 3-Monooxygenase (Registry: EC 1.14.16.2, UI: D014446); Chlorisondamine (Registry: JD3M24F66I, UI: D002714); Dopamine (Registry: VTD58H1Z2X, UI: D004298); Norepinephrine (Registry: X4W3ENH1CV, UI: D009638)
Animals (UI: D000818, Major: No); Cardiomyopathies (UI: D009202, Major: No) - Qualifiers: complications (UI: Q000150, Major: No); physiopathology (UI: Q000503, Major: Yes); Catecholamines (UI: D002395, Major: No); Chemical Phenomena (UI: D055598, Major: No); Chemistry (UI: D002621, Major: No); Chlorisondamine (UI: D002...
Animals|Cardiomyopathies|Catecholamines|Chemical Phenomena|Chemistry|Chlorisondamine|Cricetinae|Dopamine|Heart|Heart Failure|Mesocricetus|Norepinephrine|Sympathetic Nervous System|Tyrosine 3-Monooxygenase
|complications (0); physiopathology (1)||||pharmacology (0)||||complications (0)||biosynthesis (1)|physiopathology (0)|
0|0|0|0|0|0|0|0|1|0|0|0|0|0
null
1978-01-27
2019-07-06
pubmed: 1977-12-1; medline: 1977-12-1 0:1; entrez: 1977-12-1 0:0
pubmed: 21758; doi: 10.1161/01.res.41.6.814
Cardiomyopathies
[]
21,760
1
Natural history and classification of occlusive thromboaortopathy (Takayasu's disease).
MEDLINE
Manual
NLM
Fifty-four Japanese patients with occlusive thromboaortopathy (OTAP), including four males, were classified according to evidence of complications attributed to OTAP at the time when the diagnosis was established: Group I, uncomplicated OTAP with or without the involvement of the pulmonary artery. Group II, mono-compli...
Circulation
0009-7322
Print
57
1
Print
1,978
Jan
null
27-35
K Ishikawa (K)
Journal Article (D016428)
null
Adult (UI: D000328, Major: No); Aneurysm (UI: D000783, Major: No) - Qualifiers: etiology (UI: Q000209, Major: No); Aortic Arch Syndromes (UI: D001015, Major: No) - Qualifiers: pathology (UI: Q000473, Major: Yes); Aortic Valve Insufficiency (UI: D001022, Major: No) - Qualifiers: etiology (UI: Q000209, Major: No); Cerebr...
Adult|Aneurysm|Aortic Arch Syndromes|Aortic Valve Insufficiency|Cerebrovascular Disorders|Female|Heart Failure|Humans|Hypertension|Hypertension, Pulmonary|Male|Retinal Diseases|Takayasu Arteritis
|etiology (0)|pathology (1)|etiology (0)|etiology (0)||etiology (0)||etiology (0)|etiology (0)||etiology (0)|classification (0); pathology (1)
0|0|0|0|0|0|0|0|0|0|0|0|0
null
1978-01-27
2019-06-23
pubmed: 1978-1-1; medline: 1978-1-1 0:1; entrez: 1978-1-1 0:0
pubmed: 21760; doi: 10.1161/01.cir.57.1.27
Cerebrovascular Disorders
['Cerebrovascular Disorders']
21,786
1
[Minoxidil in the treatment of malignant hypertension (author's transl)].
MEDLINE
Manual
NLM
In 21 of 23 patients with hypertension unresponsive to other treatment minoxidil, a new antihypertensive drug acting via peripheral vasodilatation, lowered their blood pressure from 191 +/- 19/117 +/- 12 MM Hg to 147 +/- 13/117 +/- 12 mm Hg. The drug causes a reflex tachycardia and must therefore be combined with beta-...
Deutsche medizinische Wochenschrift (1946)
0012-0472
Print
102
48
Print
1,977
Dec
2
1766-8
D Höffler (D); H G Demers (HG)
English Abstract (D004740); Journal Article (D016428)
Adrenergic beta-Antagonists (Registry: 0, UI: D000319); Pyrimidines (Registry: 0, UI: D011743); Minoxidil (Registry: 5965120SH1, UI: D008914)
Adrenergic beta-Antagonists (UI: D000319, Major: No) - Qualifiers: therapeutic use (UI: Q000627, Major: No); Adult (UI: D000328, Major: No); Blood Pressure (UI: D001794, Major: No) - Qualifiers: drug effects (UI: Q000187, Major: No); Drug Therapy, Combination (UI: D004359, Major: No); Female (UI: D005260, Major: No); H...
Adrenergic beta-Antagonists|Adult|Blood Pressure|Drug Therapy, Combination|Female|Humans|Hypertension, Malignant|Male|Minoxidil|Pyrimidines|Tachycardia
therapeutic use (0)||drug effects (0)||||drug therapy (1)||adverse effects (0); therapeutic use (1)|therapeutic use (1)|chemically induced (0)
0|0|0|0|0|0|0|0|0|0|0
null
1978-01-27
2013-11-21
pubmed: 1977-12-2; medline: 1977-12-2 0:1; entrez: 1977-12-2 0:0
pubmed: 21786; doi: 10.1055/s-0028-1105575
Arrhythmias, Cardiac
['Tachycardia']
22,123
1
Hemodynamic effects of two cardioselective beta-adrenoceptive antagonists, metoprolol and H 87/07, in coronary insufficiency.
MEDLINE
Manual
NLM
Nineteen patients with ischemic heart disease were randomized into two groups and received either metoprolol or H 87/07. Heart catheterization was performed, and the groups were studied at rest and during exercise--before and after intravenous drug administration. During work metoprolol gave a statistically significant...
Scandinavian journal of clinical and laboratory investigation
0036-5513
Print
36
8
Print
1,976
Dec
null
755-61
L Adolfsson (L); C Sonnhag (C)
Clinical Trial (D016430); Comparative Study (D003160); Journal Article (D016428); Randomized Controlled Trial (D016449)
Adrenergic beta-Antagonists (Registry: 0, UI: D000319); Propanolamines (Registry: 0, UI: D011412); Metoprolol (Registry: GEB06NHM23, UI: D008790); Oxygen (Registry: S88TT14065, UI: D010100)
Adrenergic beta-Antagonists (UI: D000319, Major: No) - Qualifiers: pharmacology (UI: Q000494, Major: Yes); Adult (UI: D000328, Major: No); Blood Pressure (UI: D001794, Major: No) - Qualifiers: drug effects (UI: Q000187, Major: No); Cardiac Output (UI: D002302, Major: No) - Qualifiers: drug effects (UI: Q000187, Major: ...
Adrenergic beta-Antagonists|Adult|Blood Pressure|Cardiac Output|Coronary Disease|Female|Heart Rate|Hemodynamics|Humans|Male|Metoprolol|Middle Aged|Oxygen|Physical Exertion|Propanolamines
pharmacology (1)||drug effects (0)|drug effects (0)|blood (0); physiopathology (1)||drug effects (0)|drug effects (1)|||pharmacology (1)||blood (0)||pharmacology (1)
0|0|0|0|0|0|0|0|0|0|0|0|0|0|0
null
1978-01-27
2019-08-19
pubmed: 1976-12-1; medline: 1976-12-1 0:1; entrez: 1976-12-1 0:0
pubmed: 22123; doi: 10.3109/00365517609081934
Myocardial Ischemia
['Coronary Disease']
22,139
1
[Local contractility and acidosis in the ischemic myocardium of the dog (author's transl)].
MEDLINE
Manual
NLM
In open chest dogs up to 8 side branches of the R, circumflexus and descendens were embraced and could selectively be occluded. With a new developed method local myocardial length changes in the ischemic areas, and with H+-sensitive minielectrodes the interstitial H+-activities were measured. All changes which were obs...
Thoraxchirurgie, vaskulare Chirurgie
0040-6384
Print
25
4
Print
1,977
Aug
null
230-4
H Hagemann (H); M Schramm (M); E Schumacher (E); P Gaehtgens (P); H Hirche (H)
English Abstract (D004740); Journal Article (D016428)
null
Animals (UI: D000818, Major: No); Coronary Disease (UI: D003327, Major: No) - Qualifiers: physiopathology (UI: Q000503, Major: Yes); Dogs (UI: D004285, Major: No); Electrocardiography (UI: D004562, Major: No); Heart Function Tests (UI: D006334, Major: No) - Qualifiers: methods (UI: Q000379, Major: Yes); Hydrogen-Ion Co...
Animals|Coronary Disease|Dogs|Electrocardiography|Heart Function Tests|Hydrogen-Ion Concentration|Myocardial Contraction
|physiopathology (1)|||methods (1)||
0|0|0|0|0|0|1
null
1978-01-27
2006-11-15
pubmed: 1977-8-1; medline: 1977-8-1 0:1; entrez: 1977-8-1 0:0
pubmed: 22139; doi: 10.1055/s-0028-1097036
Myocardial Ischemia
['Coronary Disease']
22,247
1
Fetal reacting bradycardia.
MEDLINE
Manual
NLM
Acute and abrupt fetal bradycardia are considered to be vagal in origin. In addition to head compression and funis compression bradycardias, we will report on those acute fetal bradycardias occurring during maternal seizures and maternal voiding, during aortocaval compression, during terminal labor, and during the imme...
American journal of obstetrics and gynecology
0002-9378
Print
129
8
Print
1,977
Dec
15
845-56
R C Goodlin (RC); H C Haesslein (HC)
Comparative Study (D003160); Journal Article (D016428)
Atropine (Registry: 7C0697DR9I, UI: D001285)
Animals (UI: D000818, Major: No); Aorta (UI: D001011, Major: No) - Qualifiers: physiopathology (UI: Q000503, Major: No); Atropine (UI: D001285, Major: No) - Qualifiers: therapeutic use (UI: Q000627, Major: No); Blood (UI: D001769, Major: No); Bradycardia (UI: D001919, Major: No) - Qualifiers: drug therapy (UI: Q000188,...
Animals|Aorta|Atropine|Blood|Bradycardia|Delivery, Obstetric|Female|Fetal Diseases|Fetal Heart|Head|Heart Rate|Humans|Hydrogen-Ion Concentration|Infant, Newborn|Labor, Obstetric|Pregnancy|Pressure|Seizures|Sheep|Umbilical Arteries|Umbilical Cord|Urination|Vagus Nerve|Venae Cavae
|physiopathology (0)|therapeutic use (0)||drug therapy (0); etiology (1)|||etiology (1)|physiopathology (0)||||||||adverse effects (0)|complications (0)|||||physiopathology (0)|physiopathology (0)
0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0
null
1978-01-27
2019-06-15
pubmed: 1977-12-15; medline: 1977-12-15 0:1; entrez: 1977-12-15 0:0
pubmed: 22247; pii: 0002-9378(77)90518-X; doi: 10.1016/0002-9378(77)90518-x
Arrhythmias, Cardiac
['Bradycardia']
22,272
1
Acute hypocapneic hypokalemia: an latrogenic anesthetic complication.
MEDLINE
Manual
NLM
Hyperventilation of patients during surgical anesthesia is a common practice in the United States. The results obtained in the present study re-emphasize serum potassium concentration is directly proportional to arterial carbon dioxide tension, and that for every 10 torr decrease in PaCO2 there is a concomitant 0.5 mEq...
Anesthesia and analgesia
0003-2999
Print
56
6
Print
null
null
null
786-92
R Edwards (R); A P Winnie (AP); S Ramamurthy (S)
Journal Article (D016428)
Carbon Dioxide (Registry: 142M471B3J, UI: D002245)
Adolescent (UI: D000293, Major: No); Adult (UI: D000328, Major: No); Alkalosis, Respiratory (UI: D000472, Major: No) - Qualifiers: complications (UI: Q000150, Major: Yes); Anesthesia, General (UI: D000768, Major: No) - Qualifiers: adverse effects (UI: Q000009, Major: Yes); Arrhythmias, Cardiac (UI: D001145, Major: No) ...
Adolescent|Adult|Alkalosis, Respiratory|Anesthesia, General|Arrhythmias, Cardiac|Carbon Dioxide|Humans|Hydrogen-Ion Concentration|Hyperventilation|Hypokalemia|Iatrogenic Disease|Middle Aged
||complications (1)|adverse effects (1)|etiology (1)|blood (1)|||complications (1)|etiology (1)||
0|0|0|0|0|0|0|0|0|0|0|0
null
1978-01-27
2019-07-03
pubmed: 1977-11-1; medline: 1977-11-1 0:1; entrez: 1977-11-1 0:0
pubmed: 22272; doi: 10.1213/00000539-197711000-00009
Arrhythmias, Cardiac
[]
22,294
1
[Peroperative sinus arrest in a patient with sick sinus syndrome (apropos of a case)].
MEDLINE
Manual
NLM
A sinus arrest occured during a surgical intervention in a patient suffering from a sinus nodal dysfunction. The Fentanyl acetate used as an analgésic, seems to have played an important role in the genesis of the accident, depressing sinusal and junctional automatisms. Though unusual, this complication leads to a furth...
Annales de l'anesthesiologie francaise
0003-4061
Print
18
9
Print
1,977
null
null
730-4
G Janvier (G); J P Emérieau (JP); A Bonnet (A); R Torriélli (R); S Lévy (S)
Case Reports (D002363); Journal Article (D016428)
Thiopental (Registry: JI8Z5M7NA3, UI: D013874); Droperidol (Registry: O9U0F09D5X, UI: D004329); Fentanyl (Registry: UF599785JZ, UI: D005283)
Arrhythmia, Sinus (UI: D001146, Major: No) - Qualifiers: complications (UI: Q000150, Major: Yes); Droperidol (UI: D004329, Major: No) - Qualifiers: adverse effects (UI: Q000009, Major: Yes); Fentanyl (UI: D005283, Major: No) - Qualifiers: adverse effects (UI: Q000009, Major: Yes); Heart Block (UI: D006327, Major: No) -...
Arrhythmia, Sinus|Droperidol|Fentanyl|Heart Block|Humans|Male|Middle Aged|Neuroleptanalgesia|Sinoatrial Block|Surgical Procedures, Operative|Thiopental
complications (1)|adverse effects (1)|adverse effects (1)|chemically induced (1)||||adverse effects (1)|chemically induced (1)|adverse effects (1)|adverse effects (1)
0|0|0|0|0|0|0|0|0|0|0
null
1978-01-27
2017-11-16
pubmed: 1977-1-1; medline: 1977-1-1 0:1; entrez: 1977-1-1 0:0
pubmed: 22294
Arrhythmias, Cardiac
['Arrhythmia, Sinus', 'Heart Block']
22,297
1
[Prevention by pindolol of electrocardiographic changes during bronchoscopy performed under local and general anesthesia].
MEDLINE
Manual
NLM
Sixty patients were studied with respect to ECG modifications during bronchoscopy under local or general anesthesia, using dynamic electrocardiography. The increase in heart rate and incidence of extra-systoles were greater under local than general anesthesia. When pindolol, a beta-blocker with practically no bronchosp...
Annales de l'anesthesiologie francaise
0003-4061
Print
18
9
Print
1,977
null
null
747-51
E Erding (E); E Nalbantgil (E); B Kiliccioglu (B); I Nalbantgil (I); I Vidinel (I)
Clinical Trial (D016430); English Abstract (D004740); Journal Article (D016428); Randomized Controlled Trial (D016449)
Pindolol (Registry: BJ4HF6IU1D, UI: D010869)
Adult (UI: D000328, Major: No); Aged (UI: D000368, Major: No); Anesthesia, Inhalation (UI: D000769, Major: No) - Qualifiers: adverse effects (UI: Q000009, Major: Yes); Anesthesia, Local (UI: D000772, Major: No) - Qualifiers: adverse effects (UI: Q000009, Major: Yes); Arrhythmias, Cardiac (UI: D001145, Major: No) - Qual...
Adult|Aged|Anesthesia, Inhalation|Anesthesia, Local|Arrhythmias, Cardiac|Bronchoscopy|Drug Evaluation|Electrocardiography|Female|Heart Rate|Humans|Male|Middle Aged|Pindolol
||adverse effects (1)|adverse effects (1)|etiology (0); prevention & control (1)|adverse effects (1)||||drug effects (0)||||therapeutic use (1)
0|0|0|0|0|0|0|0|0|0|0|0|0|0
null
1978-01-27
2013-11-21
pubmed: 1977-1-1; medline: 1977-1-1 0:1; entrez: 1977-1-1 0:0
pubmed: 22297
Arrhythmias, Cardiac
[]
22,416
1
Antiarrhythmic properties of 5-(3-tert-butylamino-2-hydroxy)propoxy-3,4-dihydrocarbostyril hydrochloride (OPC-1085), a newly synthesized, potent beta-adrenoreceptor antagonist.
MEDLINE
Manual
NLM
1. The antiarrhythmic properties of 5-(3-tert-butylamino-2-hydroxy)propoxy-3,4-dihydrocarbostyril hydrochloride (opc-1085) were compared with those of propranolol and pindolol using various kinds of preparations for experimental arrhythmia in dogs. 2. Although OPC-1085 was the most potent drug to antagonize adrenaline-...
Clinical and experimental pharmacology & physiology
0305-1870
Print
4
6
Print
null
null
null
545-59
Y Yabuuchi (Y); K Hashimoto (K); S Yamashita (S); T Uno (T); S Shintani (S); N Nakagiri (N)
Comparative Study (D003160); Journal Article (D016428)
Adrenergic beta-Antagonists (Registry: 0, UI: D000319); Anesthetics, Local (Registry: 0, UI: D000779); Anti-Arrhythmia Agents (Registry: 0, UI: D000889); Propanolamines (Registry: 0, UI: D011412); Quinolines (Registry: 0, UI: D011804); Ouabain (Registry: 5ACL011P69, UI: D010042); Propranolol (Registry: 9Y8NXQ24VQ, UI: ...
Aconitine (UI: D000157, Major: No) - Qualifiers: pharmacology (UI: Q000494, Major: No); Adrenergic beta-Antagonists (UI: D000319, Major: No) - Qualifiers: pharmacology (UI: Q000494, Major: Yes); Anesthesia (UI: D000758, Major: No); Anesthetics, Local (UI: D000779, Major: No); Animals (UI: D000818, Major: No); Anti-Arrh...
Aconitine|Adrenergic beta-Antagonists|Anesthesia|Anesthetics, Local|Animals|Anti-Arrhythmia Agents|Arrhythmias, Cardiac|Coronary Vessels|Dogs|Epinephrine|Halothane|Ouabain|Pentobarbital|Pindolol|Propanolamines|Propranolol|Quinolines|Rabbits
pharmacology (0)|pharmacology (1)|||||chemically induced (0)|physiology (0)||pharmacology (0)|pharmacology (0)|pharmacology (0)||pharmacology (0)|pharmacology (1)|pharmacology (0)|pharmacology (1)|
0|0|0|0|0|1|0|0|0|0|0|0|0|0|0|0|0|0
null
1978-02-18
2019-08-23
pubmed: 1977-11-1; medline: 1977-11-1 0:1; entrez: 1977-11-1 0:0
pubmed: 22416; doi: 10.1111/j.1440-1681.1977.tb02684.x
Arrhythmias, Cardiac
[]
22,426
1
Haemodynamic observations with KO. 1366 (bunitrolol), a new beta-adrenergic blocking agent.
MEDLINE
Manual
NLM
The haemodynamic effects of a new beta-adrenergic blocking agent KO.1366 (bunitrolol) were assessed in 10 males admitted to hospital for investigation of chest pain. Measurements were made at rest, during atrial pacing at 100 beats/min, and during hand grip exercise, before and afterintravenous administration of KO.136...
Current medical research and opinion
0300-7995
Print
4
9
Print
1,977
null
null
630-4
S O Banim (SO); A da Silva (A); R Balcon (R)
Journal Article (D016428)
Adrenergic beta-Antagonists (Registry: 0, UI: D000319); Propanolamines (Registry: 0, UI: D011412)
Adrenergic beta-Antagonists (UI: D000319, Major: No) - Qualifiers: pharmacology (UI: Q000494, Major: Yes); Adult (UI: D000328, Major: No); Aged (UI: D000368, Major: No); Blood Pressure (UI: D001794, Major: No) - Qualifiers: drug effects (UI: Q000187, Major: No); Cardiac Output (UI: D002302, Major: No) - Qualifiers: dru...
Adrenergic beta-Antagonists|Adult|Aged|Blood Pressure|Cardiac Output|Coronary Disease|Heart Rate|Hemodynamics|Humans|Male|Middle Aged|Propanolamines
pharmacology (1)|||drug effects (0)|drug effects (0)|physiopathology (0)|drug effects (0)|drug effects (1)||||pharmacology (1)
0|0|0|0|0|0|0|0|0|0|0|0
null
1978-02-23
2019-09-07
pubmed: 1977-1-1; medline: 1977-1-1 0:1; entrez: 1977-1-1 0:0
pubmed: 22426; doi: 10.1185/03007997709115282
Myocardial Ischemia
['Coronary Disease']
22,481
1
[Acute myocardial infarct without pathological CK-MB isoenzyme activities].
MEDLINE
Manual
NLM
Serum CK-MB is regarded as a specific indicator for myocardial diseases. Total CK and the isoenzyme CK-MB were measured in 69 patients with myocardial infarction. In 5 of the cases no pathological CK-MB-activities have been seen. Nevertheless, the clinical importance of CK-MB determination as a differential diagnostic ...
Fortschritte der Medizin
0015-8178
Print
95
47-48
Print
1,977
Dec
15
2799-803
I Flenker (I); P Neuhausen (P); D Ricken (D); G Sabin (G)
English Abstract (D004740); Journal Article (D016428)
Isoenzymes (Registry: 0, UI: D007527); NADP (Registry: 53-59-8, UI: D009249); Hydroxybutyrate Dehydrogenase (Registry: EC 1.1.1.30, UI: D006884); Aspartate Aminotransferases (Registry: EC 2.6.1.1, UI: D001219); Creatine Kinase (Registry: EC 2.7.3.2, UI: D003402)
Aspartate Aminotransferases (UI: D001219, Major: No) - Qualifiers: metabolism (UI: Q000378, Major: No); Creatine Kinase (UI: D003402, Major: No); Diagnosis, Differential (UI: D003937, Major: No); Humans (UI: D006801, Major: No); Hydroxybutyrate Dehydrogenase (UI: D006884, Major: No) - Qualifiers: metabolism (UI: Q00037...
Aspartate Aminotransferases|Creatine Kinase|Diagnosis, Differential|Humans|Hydroxybutyrate Dehydrogenase|Isoenzymes|Myocardial Infarction|NADP
metabolism (0)||||metabolism (0)|metabolism (1)|diagnosis (0); enzymology (1)|metabolism (0)
0|0|0|0|0|0|0|0
null
1978-02-18
2006-11-15
pubmed: 1977-12-15; medline: 1977-12-15 0:1; entrez: 1977-12-15 0:0
pubmed: 22481
Myocardial Ischemia
['Myocardial Infarction']
22,591
1
The pharmacologic effects of furosemide therapy in the low-birth-weight infant.
MEDLINE
Manual
NLM
The pharmacologic effects of furosemide were studied in six infants (mean gestation 30.7 weeks; mean birth weight 1,490 gm) at ages 10 to 57 days. Furosemide (for clinical indication, standardized at 1 mg/kg) was given intravenously over one minute; data were collected over the ensuing 24 hours. For three hours followi...
The Journal of pediatrics
0022-3476
Print
92
1
Print
1,978
Jan
null
149-52
B S Ross (BS); A Pollak (A); W Oh (W)
Journal Article (D016428)
Furosemide (Registry: 7LXU5N7ZO5, UI: D005665); Sodium (Registry: 9NEZ333N27, UI: D012964); Potassium (Registry: RWP5GA015D, UI: D011188)
Furosemide (UI: D005665, Major: No) - Qualifiers: pharmacology (UI: Q000494, Major: Yes); therapeutic use (UI: Q000627, Major: No); Heart Failure (UI: D006333, Major: No) - Qualifiers: drug therapy (UI: Q000188, Major: Yes); urine (UI: Q000652, Major: No); Humans (UI: D006801, Major: No); Hydrogen-Ion Concentration (UI...
Furosemide|Heart Failure|Humans|Hydrogen-Ion Concentration|Infant|Infant, Low Birth Weight|Infant, Newborn|Infant, Newborn, Diseases|Male|Osmolar Concentration|Potassium|Sodium|Time Factors
pharmacology (1); therapeutic use (0)|drug therapy (1); urine (0)||||||drug therapy (0)|||urine (0)|urine (0)|
0|0|0|0|0|1|0|0|0|0|0|0|0
null
1978-02-18
2019-06-30
pubmed: 1978-1-1; medline: 1978-1-1 0:1; entrez: 1978-1-1 0:0
pubmed: 22591; pii: S0022-3476(78)80098-5; doi: 10.1016/s0022-3476(78)80098-5
Heart Failure
[]
22,596
1
Physostigmine's effect on diminished fetal heart rate variability caused by scopolamine, meperidine and propiomazine.
MEDLINE
Manual
NLM
Physostigmine was given to 17 patients in labor, previously given scopolamine alone or meperidine and propiomazine in combination, to ascertain its effect on reversing the loss of fetal heart rate variability caused by the administration of these drugs. The results of the study indicated that scopolamine in doses of 0....
Journal of perinatal medicine
0300-5577
Print
5
5
Print
1,977
null
null
214-22
F H Boehm (FH); A Egilmez (A); B E Smith (BE)
Journal Article (D016428)
Phenothiazines (Registry: 0, UI: D010640); Meperidine (Registry: 9E338QE28F, UI: D008614); Physostigmine (Registry: 9U1VM840SP, UI: D010830); Scopolamine (Registry: DL48G20X8X, UI: D012601)
Adolescent (UI: D000293, Major: No); Adult (UI: D000328, Major: No); Bradycardia (UI: D001919, Major: No) - Qualifiers: chemically induced (UI: Q000139, Major: No); drug therapy (UI: Q000188, Major: No); Drug Therapy, Combination (UI: D004359, Major: No); Female (UI: D005260, Major: No); Fetal Heart (UI: D005318, Major...
Adolescent|Adult|Bradycardia|Drug Therapy, Combination|Female|Fetal Heart|Heart Rate|Humans|Meperidine|Phenothiazines|Physostigmine|Pregnancy|Scopolamine
||chemically induced (0); drug therapy (0)|||drug effects (1)|drug effects (1)||adverse effects (1)|adverse effects (1)|pharmacology (1)||adverse effects (1)
0|0|0|0|0|0|0|0|0|0|0|0|0
null
1978-02-18
2019-09-18
pubmed: 1977-1-1; medline: 1977-1-1 0:1; entrez: 1977-1-1 0:0
pubmed: 22596; doi: 10.1515/jpme.1977.5.5.214
Arrhythmias, Cardiac
['Bradycardia']
22,905
1
Control of energy production in cardiac muscle: effects of ischemia in acidosis.
MEDLINE
Manual
NLM
Evidence is summarized indicating that mitochondrial respiration and citric acid cycle activity in the intact heart are controlled by the cytosolic phosphate potential and mitochondrial NAD oxidation-reduction state. Data are presented showing that the effect of respiratory acidosis is greater than that of metabolic ac...
Recent advances in studies on cardiac structure and metabolism
0363-5872
Print
11
null
Print
null
null
null
521-31
J R Williamson (JR); C Steenbergen (C); G Deleeuw (G); C Barlow (C)
Journal Article (D016428); Research Support, U.S. Gov't, P.H.S. (D013487)
NAD (Registry: 0U46U6E8UK, UI: D009243); Carbon Dioxide (Registry: 142M471B3J, UI: D002245)
Acidosis (UI: D000138, Major: No) - Qualifiers: complications (UI: Q000150, Major: No); metabolism (UI: Q000378, Major: Yes); Acidosis, Respiratory (UI: D000142, Major: No) - Qualifiers: metabolism (UI: Q000378, Major: No); Animals (UI: D000818, Major: No); Blood Pressure (UI: D001794, Major: No); Carbon Dioxide (UI: D...
Acidosis|Acidosis, Respiratory|Animals|Blood Pressure|Carbon Dioxide|Coronary Disease|Energy Metabolism|Heart|Hydrogen-Ion Concentration|In Vitro Techniques|Mitochondria, Heart|Myocardial Contraction|Myocardium|NAD|Oxidation-Reduction|Perfusion|Rats
complications (0); metabolism (1)|metabolism (0)|||pharmacology (0)|complications (0); metabolism (1)||drug effects (0); physiopathology (0)|||metabolism (0)||metabolism (1)|metabolism (0)|||
0|0|0|0|0|0|1|0|0|0|0|0|0|0|0|0|0
null
1978-02-18
2014-11-20
pubmed: 1976-5-26; medline: 1976-5-26 0:1; entrez: 1976-5-26 0:0
pubmed: 22905
Myocardial Ischemia
['Coronary Disease']
22,939
1
Chronotropism and blood flow patterns following teratogenic doses of catecholamines in 5-day-old chick embryos.
MEDLINE
Manual
NLM
In vivo heart rates of 5-day-old chick embryos were recorded from electrodes placed in close proximity to the heart. L-epinephrine (4X10(-10) mole), 1-norepinephrine (1X10(-9)mole) and 1-isoproterenol (1.6X10(-10)mole) in 5 microliter of isotonic saline transiently accerlerated the mean heart rate by almost 9 percent. ...
Teratology
0040-3709
Print
16
3
Print
1,977
Dec
null
327-43
M O Cheung (MO); E F Gilbert (EF); H J Bruyere (HJ); S Ishikawa (S); R J Hodach (RJ)
Journal Article (D016428); Research Support, U.S. Gov't, P.H.S. (D013487)
Adrenergic Agonists (Registry: 0, UI: D000322); Adrenergic beta-Agonists (Registry: 0, UI: D000318); Phenylephrine (Registry: 1WS297W6MV, UI: D010656)
Abnormalities, Drug-Induced (UI: D000014, Major: No) - Qualifiers: embryology (UI: Q000196, Major: Yes); Adrenergic Agonists (UI: D000322, Major: No) - Qualifiers: pharmacology (UI: Q000494, Major: Yes); Adrenergic beta-Agonists (UI: D000318, Major: No) - Qualifiers: pharmacology (UI: Q000494, Major: No); Animals (UI: ...
Abnormalities, Drug-Induced|Adrenergic Agonists|Adrenergic beta-Agonists|Animals|Chick Embryo|Heart|Heart Defects, Congenital|Heart Rate|Phenylephrine|Regional Blood Flow
embryology (1)|pharmacology (1)|pharmacology (0)|||embryology (1)|chemically induced (1)|drug effects (1)|pharmacology (0)|drug effects (0)
0|0|0|0|0|0|0|0|0|0
null
1978-02-18
2013-11-21
pubmed: 1977-12-1; medline: 2001-3-28 10:1; entrez: 1977-12-1 0:0
pubmed: 22939; doi: 10.1002/tera.1420160312
Heart Defects, Congenital
[]
22,958
1
[Long-term treatment with the new antiarrhythmic drug propafenone in correlation to plasma levels (author's transl)].
MEDLINE
Manual
NLM
The results of long term oral therapy of cardiac arrhythmias in 43 patients successfully treated with propafenone are reported. The patients were treated for periods ranging between 1 month and 34 months with a mean of 13.4 months. The administered dose varied between 150 mg tds and 300 mg qds with an average daily dos...
Zeitschrift fur Kardiologie
0300-5860
Print
66
11
Print
1,977
Nov
null
625-32
E Wiebringhaus (E); L Seipel (L); G Breithardt (G); F Loogen (F)
Clinical Trial (D016430); English Abstract (D004740); Journal Article (D016428)
Adrenergic beta-Antagonists (Registry: 0, UI: D000319); Anti-Arrhythmia Agents (Registry: 0, UI: D000889); Propiophenones (Registry: 0, UI: D011427)
Adrenergic beta-Antagonists (UI: D000319, Major: No) - Qualifiers: therapeutic use (UI: Q000627, Major: No); Adult (UI: D000328, Major: No); Aged (UI: D000368, Major: No); Anti-Arrhythmia Agents (UI: D000889, Major: No) - Qualifiers: administration & dosage (UI: Q000008, Major: No); blood (UI: Q000097, Major: No); ther...
Adrenergic beta-Antagonists|Adult|Aged|Anti-Arrhythmia Agents|Arrhythmias, Cardiac|Clinical Trials as Topic|Drug Evaluation|Drug Synergism|Electrocardiography|Female|Humans|Long-Term Care|Male|Middle Aged|Monitoring, Physiologic|Propiophenones
therapeutic use (0)|||administration & dosage (0); blood (0); therapeutic use (1)|blood (0); drug therapy (1)||||||||||methods (0)|administration & dosage (0); blood (0); therapeutic use (1)
0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0
null
1978-02-18
2007-11-15
pubmed: 1977-11-1; medline: 1977-11-1 0:1; entrez: 1977-11-1 0:0
pubmed: 22958
Arrhythmias, Cardiac
[]
23,032
1
[The aged heart in surgery].
MEDLINE
Manual
NLM
The risk of surgical operation is increased by the presence of heart disease. The statistics are too limited for this risk to be expressed more precisely. The heart in the elderly is no longer a normal heart. The myocardial functional reserve declines, the quality of the A.V. conduction is not always good and vascular ...
Annales de l'anesthesiologie francaise
0003-4061
Print
18
5-6
Print
1,977
null
null
433-8
A Castaigne (A)
English Abstract (D004740); Journal Article (D016428)
null
Adaptation, Physiological (UI: D000222, Major: No); Aged (UI: D000368, Major: Yes); Coronary Disease (UI: D003327, Major: No) - Qualifiers: diagnosis (UI: Q000175, Major: No); Heart (UI: D006321, Major: No) - Qualifiers: physiology (UI: Q000502, Major: Yes); Heart Conduction System (UI: D006329, Major: No) - Qualifiers...
Adaptation, Physiological|Aged|Coronary Disease|Heart|Heart Conduction System|Humans|Patient Care Planning|Preoperative Care|Surgical Procedures, Operative
||diagnosis (0)|physiology (1)|physiology (0)||||
0|1|0|0|0|0|0|0|1
null
1978-02-18
2006-11-15
pubmed: 1977-1-1; medline: 1977-1-1 0:1; entrez: 1977-1-1 0:0
pubmed: 23032
Myocardial Ischemia
['Coronary Disease']
23,713
1
Chest pain: coronary or esophageal?
MEDLINE
Manual
NLM
Although it is often relatively easy for the clinician to differentiate between the heart and the esophagus as sources of chest pain, there remains a substantial minority of patients in whom this task is difficult. We have attempted to review points of differential significance which can be elicited through assessment ...
Angiology
0003-3197
Print
28
12
Print
1,977
Dec
null
832-8
H M Rosenthal (HM); J N Cooper (JN)
Journal Article (D016428); Review (D016454)
null
Angina Pectoris (UI: D000787, Major: No) - Qualifiers: complications (UI: Q000150, Major: No); diagnosis (UI: Q000175, Major: Yes); Esophageal Diseases (UI: D004935, Major: No) - Qualifiers: complications (UI: Q000150, Major: Yes); diagnosis (UI: Q000175, Major: Yes); diagnostic imaging (UI: Q000000981, Major: No); Eso...
Angina Pectoris|Esophageal Diseases|Esophagitis, Peptic|Esophagoscopy|Esophagus|Gastroesophageal Reflux|Humans|Hydrogen-Ion Concentration|Manometry|Pain|Radiography|Radionuclide Imaging|Spasm|Time Factors
complications (0); diagnosis (1)|complications (1); diagnosis (1); diagnostic imaging (0)|complications (0)||physiopathology (0)|diagnosis (0); diagnostic imaging (0)|||||||complications (0); diagnosis (0); diagnostic imaging (0)|
0|0|0|0|0|0|0|0|0|0|0|0|0|0
null
1978-03-21
2017-02-14
pubmed: 1977-12-1; medline: 1977-12-1 0:1; entrez: 1977-12-1 0:0
pubmed: 23713; doi: 10.1177/000331977702801203
Myocardial Ischemia
['Angina Pectoris']
23,798
1
Experiments in animals on the pharmacological effects of metipranolol in comparison with propranolol and pindolol.
MEDLINE
Manual
NLM
The beta-blocking agent 1-(4-acetoxy-2,3,5-trimethylphenyloxy)-3-isopropylamino-propan-2-ol (metipranolol) was compared with propranolol and pindolol. The beta-blocking activity on isoproterenol induced tachycardia was determined in rabbits (ED250bpm). The following doses in microgram/kg i.v. were required to produce t...
Arzneimittel-Forschung
0004-4172
Print
27
12
Print
1,977
null
null
2319-22
W Bartsch (W); G Sponer (G); K Dietmann (K)
Comparative Study (D003160); Journal Article (D016428)
Adrenergic beta-Antagonists (Registry: 0, UI: D000319); Propanolamines (Registry: 0, UI: D011412); Propranolol (Registry: 9Y8NXQ24VQ, UI: D011433); Pindolol (Registry: BJ4HF6IU1D, UI: D010869); Isoproterenol (Registry: L628TT009W, UI: D007545)
Adrenergic beta-Antagonists (UI: D000319, Major: No) - Qualifiers: pharmacology (UI: Q000494, Major: Yes); Animals (UI: D000818, Major: No); Atrial Fibrillation (UI: D001281, Major: No) - Qualifiers: physiopathology (UI: Q000503, Major: No); Cornea (UI: D003315, Major: No) - Qualifiers: drug effects (UI: Q000187, Major...
Adrenergic beta-Antagonists|Animals|Atrial Fibrillation|Cornea|Gluconeogenesis|Heart|Hypoxia|In Vitro Techniques|Isoproterenol|Membranes|Pindolol|Propanolamines|Propranolol|Rabbits
pharmacology (1)||physiopathology (0)|drug effects (0)|drug effects (0)|drug effects (0)|physiopathology (0)||antagonists & inhibitors (0)|drug effects (0)|pharmacology (1)|pharmacology (1)|pharmacology (1)|
0|0|0|0|0|0|0|0|0|0|0|0|0|0
null
1978-03-10
2016-11-23
pubmed: 1977-1-1; medline: 1977-1-1 0:1; entrez: 1977-1-1 0:0
pubmed: 23798
Arrhythmias, Cardiac
['Atrial Fibrillation']
24,153
1
[Bullet embolism of the median cerebral artery].
MEDLINE
Manual
NLM
A shot injury to the middle cerebral artery caused occlusion to the vessel by thrombosis and emboly of the missile. The projectil had been removed, but a thrombus formed in the a. cerebri media as a postoperative complication or by progression of a thrombosis in the internal carotid artery and after 19 days the patient...
Magyar traumatologia, orthopaedia es helyreallito sebeszet
0025-0317
Print
21
1
Print
1,978
null
null
75-9
F Kósa (F); I Bajnóczky (I); E Huszka (E)
Case Reports (D002363); Journal Article (D016428)
null
Adult (UI: D000328, Major: No); Carotid Artery Injuries (UI: D020212, Major: No); Carotid Artery, Internal (UI: D002343, Major: No) - Qualifiers: diagnostic imaging (UI: Q000000981, Major: No); Cerebral Angiography (UI: D002533, Major: No); Cerebral Arteries (UI: D002536, Major: No) - Qualifiers: injuries (UI: Q000293,...
Adult|Carotid Artery Injuries|Carotid Artery, Internal|Cerebral Angiography|Cerebral Arteries|Humans|Intracranial Embolism and Thrombosis|Male|Wounds, Gunshot
||diagnostic imaging (0)||injuries (1)||etiology (1)||complications (1); diagnostic imaging (0)
0|0|0|0|0|0|0|0|0
null
1978-04-26
2016-11-23
pubmed: 1978-1-1; medline: 1978-1-1 0:1; entrez: 1978-1-1 0:0
pubmed: 24153
Cerebrovascular Disorders
['Intracranial Embolism and Thrombosis']
24,776
1
Pharmacology of Sch 11973, N-(2-phenylisopropyl)-N-p-toluene sulfonyl urea, a potential new antianginal agent.
MEDLINE
Manual
NLM
Antianginal drugs were evaluated on the basis of their ability to protect against subepicardial electrogram changes induced by local ventricular ischemia in anesthetized dogs. Sch 11973 [N-(2-phenylisopropyl)-N-p-toluene sulfonyl urea], a potential new antianginal agent, was also effective against local ventricular isc...
Japanese journal of pharmacology
0021-5198
Print
27
6
Print
1,977
Dec
null
769-79
L Zitowitz (L); J Stimson (J); A J Wohl (AJ); S J Ehrreich (SJ)
Comparative Study (D003160); Journal Article (D016428)
Adrenergic beta-Antagonists (Registry: 0, UI: D000319); Sulfonylurea Compounds (Registry: 0, UI: D013453); Dipyridamole (Registry: 64ALC7F90C, UI: D004176); Propranolol (Registry: 9Y8NXQ24VQ, UI: D011433); Nitroglycerin (Registry: G59M7S0WS3, UI: D005996); tosifen (Registry: OK1IHO7PG8, UI: C016865)
Adrenergic beta-Antagonists (UI: D000319, Major: No); Angina Pectoris (UI: D000787, Major: No) - Qualifiers: drug therapy (UI: Q000188, Major: Yes); Animals (UI: D000818, Major: No); Coronary Disease (UI: D003327, Major: No) - Qualifiers: drug therapy (UI: Q000188, Major: No); Dipyridamole (UI: D004176, Major: No) - Qu...
Adrenergic beta-Antagonists|Angina Pectoris|Animals|Coronary Disease|Dipyridamole|Disease Models, Animal|Dogs|Dose-Response Relationship, Drug|Drug Evaluation|Female|Heart Rate|Heart Ventricles|Male|Nitroglycerin|Propranolol|Sulfonylurea Compounds
|drug therapy (1)||drug therapy (0)|pharmacology (0)||||||drug effects (0)|drug effects (0)||pharmacology (0)|pharmacology (0)|administration & dosage (0); pharmacology (1)
0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0
null
1978-05-17
2019-12-10
pubmed: 1977-12-1; medline: 1977-12-1 0:1; entrez: 1977-12-1 0:0
pubmed: 24776; doi: 10.1254/jjp.27.769
Myocardial Ischemia
['Angina Pectoris', 'Coronary Disease']
24,985
1
Auricular tyrosine hydroxylase and dopamine-beta-hydroxylase activities and noradrenaline content in ischaemic heart disease.
MEDLINE
Manual
NLM
Assessments were made of the tyrosine hydroxylase (TH) and dopamine-beta-hydroxylase (DBH) activities as well as the noradrenaline (NA) content of samples excised from right auricular tissue during cardiac surgery on a total of 55 patients with ischaemic heart disease (IHD), valvular heart disease (VHD), uncomplicated ...
Acta medica Scandinavica
0001-6101
Print
203
3
Print
1,978
null
null
161-6
O Penttilä (O); E Merikallio (E); J Pispa (J); E Klinge (E); P Siltanen (P); K Kyösola (K)
Journal Article (D016428)
Tyrosine 3-Monooxygenase (Registry: EC 1.14.16.2, UI: D014446); Dopamine beta-Hydroxylase (Registry: EC 1.14.17.1, UI: D004299); Norepinephrine (Registry: X4W3ENH1CV, UI: D009638)
Adult (UI: D000328, Major: No); Coronary Disease (UI: D003327, Major: No) - Qualifiers: enzymology (UI: Q000201, Major: No); metabolism (UI: Q000378, Major: Yes); Dopamine beta-Hydroxylase (UI: D004299, Major: No) - Qualifiers: metabolism (UI: Q000378, Major: Yes); Female (UI: D005260, Major: No); Heart Atria (UI: D006...
Adult|Coronary Disease|Dopamine beta-Hydroxylase|Female|Heart Atria|Heart Failure|Heart Septal Defects, Atrial|Heart Valve Diseases|Humans|Male|Middle Aged|Myocardium|Norepinephrine|Tyrosine 3-Monooxygenase
|enzymology (0); metabolism (1)|metabolism (1)|||enzymology (0)|enzymology (0)|enzymology (0)||||enzymology (0); metabolism (1)|metabolism (1)|metabolism (1)
0|0|0|0|0|0|0|0|0|0|0|0|0|0
null
1978-05-08
2019-08-12
pubmed: 1978-1-1; medline: 1978-1-1 0:1; entrez: 1978-1-1 0:0
pubmed: 24985; doi: 10.1111/j.0954-6820.1978.tb14850.x
Myocardial Ischemia
['Coronary Disease']
25,156
1
Diseases and drug protein binding.
MEDLINE
Manual
NLM
In a number of pathological states a decrease in the plasma protein binding of drugs is observed. This may be due to many factors related either to the protein, or the ligand (drug), or to the binding conditions. The most important of these disease states quantitatively are probably hypoalbuminaemia, conditions resulti...
Clinical pharmacokinetics
0312-5963
Print
3
2
Print
null
null
null
144-54
J P Tillement (JP); F Lhoste (F); J F Giudicelli (JF)
Journal Article (D016428); Review (D016454)
Blood Proteins (Registry: 0, UI: D001798); Fatty Acids, Nonesterified (Registry: 0, UI: D005230); Serum Albumin (Registry: 0, UI: D012709); Bilirubin (Registry: RFM9X3LJ49, UI: D001663)
Bilirubin (UI: D001663, Major: No) - Qualifiers: metabolism (UI: Q000378, Major: No); Blood Proteins (UI: D001798, Major: No) - Qualifiers: metabolism (UI: Q000378, Major: Yes); Body Fluid Compartments (UI: D001825, Major: No) - Qualifiers: metabolism (UI: Q000378, Major: No); Deficiency Diseases (UI: D003677, Major: N...
Bilirubin|Blood Proteins|Body Fluid Compartments|Deficiency Diseases|Fatty Acids, Nonesterified|Heart Failure|Humans|Hydrogen-Ion Concentration|Kidney Failure, Chronic|Liver Diseases|Nephrotic Syndrome|Protein Binding|Serum Albumin
metabolism (0)|metabolism (1)|metabolism (0)|metabolism (0)|metabolism (0)|metabolism (0)|||metabolism (0)|metabolism (0)|metabolism (0)||deficiency (0); metabolism (0)
0|0|0|0|0|0|0|0|0|0|0|1|0
null
1978-06-12
2018-11-13
pubmed: 1978-3-1; medline: 1978-3-1 0:1; entrez: 1978-3-1 0:0
pubmed: 5823761; doi: 10.2165/00003088-197803020-00004
Heart Failure
[]
25,706
1
Cardiac pharmacology and cardiomyopathy in Friedreich's ataxia.
MEDLINE
Manual
NLM
Friedreich's ataxia is almost always associated with a cardiomyopathy. The cardiomyopathy and its attendant cardiopulmonary sequelae is the usual cause of death in this disease. The author reviews the known pharmacology of the heart, particularly as it applies to hypertrophic cardiomyopathy. The important role played b...
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques
0317-1671
Print
5
1
Print
1,978
Feb
null
83-91
R J Huxtable (RJ)
Journal Article (D016428)
Adrenergic beta-Agonists (Registry: 0, UI: D000318); Adrenergic beta-Antagonists (Registry: 0, UI: D000319); Cardiac Glycosides (Registry: 0, UI: D002301); Calcium (Registry: SY7Q814VUP, UI: D002118)
Adrenergic beta-Agonists (UI: D000318, Major: No) - Qualifiers: pharmacology (UI: Q000494, Major: No); Adrenergic beta-Antagonists (UI: D000319, Major: No) - Qualifiers: pharmacology (UI: Q000494, Major: No); Calcium (UI: D002118, Major: No) - Qualifiers: metabolism (UI: Q000378, Major: No); Cardiac Glycosides (UI: D00...
Adrenergic beta-Agonists|Adrenergic beta-Antagonists|Calcium|Cardiac Glycosides|Cardiomyopathies|Friedreich Ataxia|Humans|Hypertension, Pulmonary|Myocardium|Scoliosis
pharmacology (0)|pharmacology (0)|metabolism (0)|pharmacology (0)|drug therapy (0); etiology (1)|complications (1); metabolism (0)||complications (0)|metabolism (0)|complications (0)
0|0|0|0|0|0|0|0|0|0
null
1978-07-24
2013-11-21
pubmed: 1978-2-1; medline: 1978-2-1 0:1; entrez: 1978-2-1 0:0
pubmed: 25706
Cardiomyopathies
[]
25,705
1
Brain metabolism and arterial acid-base balance following bilateral carotid occlusion in normotensive and experimental hypertensive rats.
MEDLINE
Manual
NLM
The effects of bilateral common carotid artery occlusion on brain metabolism and arterial acid-base balance were studied in normotensive and experimental renovascular hypertensive rats. One hour after carotid occlusion in hypertensive rats, supratentorial lactate increased to 383% and lactate-pyruvate ratio to 280% of ...
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques
0317-1671
Print
5
1
Print
1,978
Feb
null
27-32
M Fujishima (M); Y Morotomi (Y); K Tamaki (K); Y Nakatomi (Y); J Ogata (J); S Takishita (S); K Kumamoto (K); K Fukiyama (K); T Omae (T)
Journal Article (D016428)
Lactates (Registry: 0, UI: D007773); Pyruvates (Registry: 0, UI: D011773); Carbon Dioxide (Registry: 142M471B3J, UI: D002245); Adenosine Triphosphate (Registry: 8L70Q75FXE, UI: D000255); Oxygen (Registry: S88TT14065, UI: D010100)
Acid-Base Equilibrium (UI: D000136, Major: Yes); Adenosine Triphosphate (UI: D000255, Major: No) - Qualifiers: metabolism (UI: Q000378, Major: No); Animals (UI: D000818, Major: No); Brain (UI: D001921, Major: No) - Qualifiers: metabolism (UI: Q000378, Major: Yes); Carbon Dioxide (UI: D002245, Major: No) - Qualifiers: b...
Acid-Base Equilibrium|Adenosine Triphosphate|Animals|Brain|Carbon Dioxide|Carotid Arteries|Carotid Artery Diseases|Constriction|Hydrogen-Ion Concentration|Hypertension, Renal|Lactates|Male|Oxygen|Pyruvates|Rats
|metabolism (0)||metabolism (1)|blood (0)|physiology (0)|complications (0); metabolism (1)|||blood (0); complications (0); metabolism (1)|metabolism (0)||blood (0)|metabolism (0)|
1|0|0|0|0|0|0|0|0|0|0|0|0|0|0
null
1978-07-24
2013-11-21
pubmed: 1978-2-1; medline: 1978-2-1 0:1; entrez: 1978-2-1 0:0
pubmed: 25705
Cerebrovascular Disorders
['Carotid Artery Diseases']
25,708
1
Minor tranquillizers in somatic disorders.
MEDLINE
Manual
NLM
Conclusive evidence of improved outcome due to adjunctive anxiolytic therapy in some somatic conditions is lacking. However, such therapy may facilitate patient management without being ""curative"". The resulting improved feeling of well-being may be of value in the management of gastrointestinal disorders, migraine a...
Canadian Medical Association journal
0008-4409
Print
118
9
Print
1,978
May
6
1097, 1100-2, 1107-8
C Krogh (C); W M McLean (WM); Y D LaPierre (YD)
Journal Article (D016428); Review (D016454)
Anti-Anxiety Agents (Registry: 0, UI: D014151)
Angina Pectoris (UI: D000787, Major: No) - Qualifiers: drug therapy (UI: Q000188, Major: No); Anti-Anxiety Agents (UI: D014151, Major: No) - Qualifiers: therapeutic use (UI: Q000627, Major: Yes); Asthma (UI: D001249, Major: No) - Qualifiers: drug therapy (UI: Q000188, Major: No); Gastrointestinal Diseases (UI: D005767,...
Angina Pectoris|Anti-Anxiety Agents|Asthma|Gastrointestinal Diseases|Humans|Hypertension|Migraine Disorders|Myocardial Infarction|Respiratory Tract Diseases
drug therapy (0)|therapeutic use (1)|drug therapy (0)|drug therapy (0)||drug therapy (0)|drug therapy (0)|drug therapy (0)|drug therapy (0)
0|0|0|0|0|0|0|0|0
null
1978-07-24
2018-11-13
pubmed: 1978-5-6; medline: 1978-5-6 0:1; entrez: 1978-5-6 0:0
pubmed: 973905; pmc: PMC1818696
Myocardial Ischemia
['Angina Pectoris', 'Myocardial Infarction']
25,714
1
Evidence for the detrimental effect of adrenaline infused to healthy dogs in doses imitating spontaneous secretion after coronary occlusion.
MEDLINE
Manual
NLM
We have previously shown that acute coronary occlusion in the dog is often accompanied by increased adrenaline release into the blood. In the present study the consequences of this humoral reaction were studied in anaesthetised healthy mongrel dogs subjected to adrenaline infusion administered at a rate relevant to spo...
Cardiovascular research
0008-6363
Print
12
3
Print
1,978
Mar
null
179-89
L Ceremuzyński (L); K Herbaczyńska-Cedro (K); B Broniszewska-Ardelt (B); J Nauman (J); A Nauman (A); B Woźniewicz (B); J Lawecki (J)
Journal Article (D016428)
Fatty Acids, Nonesterified (Registry: 0, UI: D005230); Triiodothyronine (Registry: 06LU7C9H1V, UI: D014284); Carbon Dioxide (Registry: 142M471B3J, UI: D002245); Epinephrine (Registry: YKH834O4BH, UI: D004837)
Animals (UI: D000818, Major: No); Carbon Dioxide (UI: D002245, Major: No) - Qualifiers: blood (UI: Q000097, Major: No); Coronary Disease (UI: D003327, Major: No) - Qualifiers: physiopathology (UI: Q000503, Major: Yes); Dogs (UI: D004285, Major: No); Epinephrine (UI: D004837, Major: No) - Qualifiers: administration & do...
Animals|Carbon Dioxide|Coronary Disease|Dogs|Epinephrine|Fatty Acids, Nonesterified|Heart|Hydrogen-Ion Concentration|Microscopy, Electron|Mitochondria, Heart|Myocardium|Triiodothyronine
|blood (0)|physiopathology (1)||administration & dosage (0); metabolism (0); pharmacology (1)|blood (0)|drug effects (1)|||drug effects (0); enzymology (0); ultrastructure (0)|enzymology (1)|blood (0)
0|0|0|0|0|0|0|0|0|0|0|0
null
1978-07-26
2019-05-09
pubmed: 1978-3-1; medline: 1978-3-1 0:1; entrez: 1978-3-1 0:0
pubmed: 25714; doi: 10.1093/cvr/12.3.179
Myocardial Ischemia
['Coronary Disease']
25,720
1
Coronary arterial spasm and Prinzmetal's variant form of angina induced by hyperventilation and Tris-buffer infusion.
MEDLINE
Manual
NLM
Vigorous hyperventilation was induced for five minutes immediately after a five-minute infusion of 100 ml of Tris-buffer (pH 10) in nine patients with Prinzmetal's variant angina. In eight of the patients, chest pain with ischemic changes in the electrocardiogram occurred during this procedure or within five minutes af...
Circulation
0009-7322
Print
58
1
Print
1,978
Jul
null
56-62
H Yasue (H); M Nagao (M); S Omote (S); A Takizawa (A); K Miwa (K); S Tanaka (S)
Journal Article (D016428)
Tromethamine (Registry: 023C2WHX2V, UI: D014325); Diltiazem (Registry: EE92BBP03H, UI: D004110); Calcium (Registry: SY7Q814VUP, UI: D002118)
Angina Pectoris (UI: D000787, Major: No) - Qualifiers: etiology (UI: Q000209, Major: Yes); Angina Pectoris, Variant (UI: D000788, Major: No) - Qualifiers: etiology (UI: Q000209, Major: Yes); Calcium (UI: D002118, Major: No) - Qualifiers: antagonists & inhibitors (UI: Q000037, Major: No); Cineangiography (UI: D002932, M...
Angina Pectoris|Angina Pectoris, Variant|Calcium|Cineangiography|Coronary Angiography|Coronary Disease|Diltiazem|Electrocardiography|Female|Humans|Hydrogen-Ion Concentration|Hyperventilation|Male|Middle Aged|Spasm|Tromethamine
etiology (1)|etiology (1)|antagonists & inhibitors (0)|||etiology (1)|pharmacology (0)|||||complications (1)|||etiology (0)|adverse effects (1)
0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0
null
1978-07-24
2022-04-08
pubmed: 1978-7-1; medline: 1978-7-1 0:1; entrez: 1978-7-1 0:0
pubmed: 25720; doi: 10.1161/01.cir.58.1.56
Myocardial Ischemia
['Angina Pectoris', 'Coronary Disease']
26,159
1
Cardiovascular effects of local adrenaline infiltration during halothane anaesthesia and adrenergic beta-receptor blockade in man.
MEDLINE
Manual
NLM
Adrenergic beta-receptor blocking agents, alprenolol, propranolol and practolol were given as a prophylactic measure to patients undergoing middle-ear microsurgery where adrenaline was deliberately infiltrated during halothane-N2O/O2 anaesthesia. These three beta blockers did not differ in their action on heart rate, a...
Acta anaesthesiologica Scandinavica
0001-5172
Print
22
2
Print
1,978
null
null
130-44
P J Pöntinen (PJ)
Journal Article (D016428)
Adrenergic beta-Antagonists (Registry: 0, UI: D000319); Atropine (Registry: 7C0697DR9I, UI: D001285); Alprenolol (Registry: 877K5MQ27W, UI: D000526); Propranolol (Registry: 9Y8NXQ24VQ, UI: D011433); Practolol (Registry: SUG9176GRW, UI: D011217); Halothane (Registry: UQT9G45D1P, UI: D006221); Epinephrine (Registry: YKH8...
Adolescent (UI: D000293, Major: No); Adrenergic beta-Antagonists (UI: D000319, Major: No) - Qualifiers: therapeutic use (UI: Q000627, Major: Yes); Adult (UI: D000328, Major: No); Alprenolol (UI: D000526, Major: No) - Qualifiers: therapeutic use (UI: Q000627, Major: No); Anesthesia, General (UI: D000768, Major: Yes); Ar...
Adolescent|Adrenergic beta-Antagonists|Adult|Alprenolol|Anesthesia, General|Arrhythmias, Cardiac|Atropine|Blood Pressure|Child|Epinephrine|Female|Halothane|Heart Rate|Hemodynamics|Humans|Male|Middle Aged|Monitoring, Physiologic|Practolol|Propranolol
|therapeutic use (1)||therapeutic use (0)||chemically induced (1); prevention & control (0)|pharmacology (0)|drug effects (0)||adverse effects (1)||adverse effects (0)|drug effects (0)|drug effects (1)|||||therapeutic use (0)|therapeutic use (0)
0|0|0|0|1|0|0|0|0|0|0|1|0|0|0|0|0|0|0|0
null
1978-07-15
2019-08-14
pubmed: 1978-1-1; medline: 1978-1-1 0:1; entrez: 1978-1-1 0:0
pubmed: 26159; doi: 10.1111/j.1399-6576.1978.tb01290.x
Arrhythmias, Cardiac
[]
26,160
1
Cardiovascular effects of local adrenaline infiltration during neurolept analgesia and adrenergic beta-receptor blockade in man.
MEDLINE
Manual
NLM
The adrenergic beta-receptor blocking drug, alprenolol, was given together with atropine to 15 patients during neurolept analgesia (NLA) in order to prevent adrenaline-induced cardiac arrhythmias. Four patients operated on without adrenergic beta-receptor blockade formed the control group. Three of them developed tachy...
Acta anaesthesiologica Scandinavica
0001-5172
Print
22
2
Print
1,978
null
null
145-53
P J Pöntinen (PJ)
Journal Article (D016428)
Adrenergic beta-Antagonists (Registry: 0, UI: D000319); Atropine (Registry: 7C0697DR9I, UI: D001285); Alprenolol (Registry: 877K5MQ27W, UI: D000526); Propranolol (Registry: 9Y8NXQ24VQ, UI: D011433); Epinephrine (Registry: YKH834O4BH, UI: D004837)
Adolescent (UI: D000293, Major: No); Adrenergic beta-Antagonists (UI: D000319, Major: No) - Qualifiers: therapeutic use (UI: Q000627, Major: Yes); Adult (UI: D000328, Major: No); Aged (UI: D000368, Major: No); Alprenolol (UI: D000526, Major: No) - Qualifiers: therapeutic use (UI: Q000627, Major: No); Arrhythmias, Cardi...
Adolescent|Adrenergic beta-Antagonists|Adult|Aged|Alprenolol|Arrhythmias, Cardiac|Atropine|Blood Pressure|Epinephrine|Female|Heart Rate|Hemodynamics|Humans|Male|Middle Aged|Neuroleptanalgesia|Propranolol
|therapeutic use (1)|||therapeutic use (0)|chemically induced (0); drug therapy (0); prevention & control (0)|therapeutic use (0)|drug effects (0)|adverse effects (1)||drug effects (0)|drug effects (1)|||||therapeutic use (0)
0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|1|0
null
1978-07-15
2019-08-14
pubmed: 1978-1-1; medline: 1978-1-1 0:1; entrez: 1978-1-1 0:0
pubmed: 26160; doi: 10.1111/j.1399-6576.1978.tb01291.x
Arrhythmias, Cardiac
[]
26,214
1
Involvement of the cardiac conducting system in panarteritis nodosa.
MEDLINE
Manual
NLM
Histopathological observations on the conduction system of the heart were carried out in three cases of panarteritis nodosa. This specialized tissue was involved in each case secondary to ischemia and/or periarterial extension of the inflammatory process affecting the nutrient arteries of the conducting system. The hig...
American heart journal
0002-8703
Print
95
6
Print
1,978
Jun
null
716-24
G Thiene (G); M Valente (M); L Rossi (L)
Case Reports (D002363); Journal Article (D016428)
null
Adult (UI: D000328, Major: No); Atrioventricular Node (UI: D001283, Major: No) - Qualifiers: pathology (UI: Q000473, Major: No); Bundle of His (UI: D002036, Major: No) - Qualifiers: pathology (UI: Q000473, Major: No); Child (UI: D002648, Major: No); Coronary Disease (UI: D003327, Major: No) - Qualifiers: etiology (UI: ...
Adult|Atrioventricular Node|Bundle of His|Child|Coronary Disease|Electrocardiography|Female|Heart Conduction System|Humans|Male|Polyarteritis Nodosa
|pathology (0)|pathology (0)||etiology (1); pathology (0); physiopathology (0)|||pathology (0); physiopathology (0)|||complications (1); pathology (0); physiopathology (0)
0|0|0|0|0|0|0|1|0|0|0
null
1978-07-24
2019-06-26
pubmed: 1978-6-1; medline: 1978-6-1 0:1; entrez: 1978-6-1 0:0
pubmed: 26214; pii: 0002-8703(78)90501-X; doi: 10.1016/0002-8703(78)90501-x
Myocardial Ischemia
['Coronary Disease']
26,254
1
[Survived brain infarction in old age - clinical and morphological findings. part I: extracranial stenoses of carotis arteries (author's transl)].
MEDLINE
Manual
NLM
By clinical and post mortem findings we searched for the risk factors, important for brain infarctions in people of nearly 80 years. We were especially interested in the conditions of the extracranial vessels such as the carotid arteries and the murmurs at this point. The number of arterial stenoses in this region, asc...
Aktuelle Gerontologie
0300-5704
Print
8
3
Print
1,978
Mar
null
133-8
H Zapfe (H); S Feldmann (S)
English Abstract (D004740); Journal Article (D016428)
null
Age Factors (UI: D000367, Major: No); Aged (UI: D000368, Major: No); Autopsy (UI: D001344, Major: No); Carotid Artery Diseases (UI: D002340, Major: No) - Qualifiers: complications (UI: Q000150, Major: No); Constriction, Pathologic (UI: D003251, Major: No) - Qualifiers: complications (UI: Q000150, Major: No); Humans (UI...
Age Factors|Aged|Autopsy|Carotid Artery Diseases|Constriction, Pathologic|Humans|Intracranial Embolism and Thrombosis|Risk
|||complications (0)|complications (0)||etiology (1); pathology (0)|
0|0|0|0|0|0|0|0
null
1978-07-15
2006-11-15
pubmed: 1978-3-1; medline: 1978-3-1 0:1; entrez: 1978-3-1 0:0
pubmed: 26254
Cerebrovascular Disorders
['Carotid Artery Diseases', 'Intracranial Embolism and Thrombosis']
26,257
1
[Results of a comparing study concerning men under 40 years old and above 60 years, affected by myocardial infarction (author's transl)].
MEDLINE
Manual
NLM
We examined a group of 300 men in the age of under 40 and a comparing group of 300 men in the age of 60 and more years, with clinically or histologically ascertained heart infarct (according to criterions of (WHO). Our work brought the proof that clinically unambiguous heart-infarct in the group of men under 40 years w...
Aktuelle Gerontologie
0300-5704
Print
8
3
Print
1,978
Mar
null
149-52
B Zdichynec (B)
Comparative Study (D003160); English Abstract (D004740); Journal Article (D016428)
Triglycerides (Registry: 0, UI: D014280); Cholesterol (Registry: 97C5T2UQ7J, UI: D002784)
Adult (UI: D000328, Major: No); Age Factors (UI: D000367, Major: No); Cholesterol (UI: D002784, Major: No) - Qualifiers: blood (UI: Q000097, Major: No); Humans (UI: D006801, Major: No); Hypercholesterolemia (UI: D006937, Major: No) - Qualifiers: complications (UI: Q000150, Major: No); Hyperlipidemias (UI: D006949, Majo...
Adult|Age Factors|Cholesterol|Humans|Hypercholesterolemia|Hyperlipidemias|Male|Middle Aged|Myocardial Infarction|Risk|Smoking|Triglycerides
||blood (0)||complications (0)|complications (0)|||etiology (1); genetics (0)||complications (0)|blood (0)
0|0|0|0|0|0|0|0|0|0|0|0
null
1978-07-15
2013-11-21
pubmed: 1978-3-1; medline: 1978-3-1 0:1; entrez: 1978-3-1 0:0
pubmed: 26257
Myocardial Ischemia
['Myocardial Infarction']
26,299
1
Advantages and disadvantages of beta-adrenergic blocking drugs in hypertension.
MEDLINE
Manual
NLM
This paper reviews the role of beta-adrenergic blocking drugs in the treatment of hypertension. A significant proportion of patients presenting with mild or moderate hypertension will respond to general measures and do not require specific drug therapy. Of the remaining patients, some will respond to treatment with a t...
Angiology
0003-3197
Print
29
4
Print
1,978
Apr
null
332-6
E T O'Brien (ET)
Journal Article (D016428); Review (D016454)
Adrenergic beta-Antagonists (Registry: 0, UI: D000319); Benzothiadiazines (Registry: 0, UI: D001581); Diuretics (Registry: 0, UI: D004232); Sodium Chloride Symporter Inhibitors (Registry: 0, UI: D049993); Vasodilator Agents (Registry: 0, UI: D014665)
Adrenergic beta-Antagonists (UI: D000319, Major: No) - Qualifiers: adverse effects (UI: Q000009, Major: No); therapeutic use (UI: Q000627, Major: Yes); Angina Pectoris (UI: D000787, Major: No) - Qualifiers: drug therapy (UI: Q000188, Major: No); Anxiety (UI: D001007, Major: No) - Qualifiers: drug therapy (UI: Q000188, ...
Adrenergic beta-Antagonists|Angina Pectoris|Anxiety|Arrhythmias, Cardiac|Benzothiadiazines|Diuretics|Humans|Hypertension|Sodium Chloride Symporter Inhibitors|Vasodilator Agents
adverse effects (0); therapeutic use (1)|drug therapy (0)|drug therapy (0)|drug therapy (0)||||drug therapy (1)|therapeutic use (0)|therapeutic use (0)
0|0|0|0|0|0|0|0|0|0
null
1978-07-26
2017-02-14
pubmed: 1978-4-1; medline: 1978-4-1 0:1; entrez: 1978-4-1 0:0
pubmed: 26299; doi: 10.1177/000331977802900410
Myocardial Ischemia
['Angina Pectoris']
26,329
1
On the mode of action of antianginal drugs.
MEDLINE
Manual
NLM
The antianginal action of coronary dilating drugs seems to be related at least partly to their effect of improving the blood supply of the ischemic myocardium. No correlation was found between coronary dilating action of these drugs in the normal myocardium and in the ischemic area, however. It has been shown that coro...
Basic research in cardiology
0300-8428
Print
73
2
Print
null
null
null
133-46
L Szekeres (L)
Journal Article (D016428)
Adrenergic beta-Antagonists (Registry: 0, UI: D000319); Lactates (Registry: 0, UI: D007773); Vasodilator Agents (Registry: 0, UI: D014665)
Adrenergic beta-Antagonists (UI: D000319, Major: No) - Qualifiers: pharmacology (UI: Q000494, Major: No); therapeutic use (UI: Q000627, Major: No); Angina Pectoris (UI: D000787, Major: No) - Qualifiers: drug therapy (UI: Q000188, Major: Yes); Animals (UI: D000818, Major: No); Coronary Circulation (UI: D003326, Major: N...
Adrenergic beta-Antagonists|Angina Pectoris|Animals|Coronary Circulation|Coronary Vessels|Depression, Chemical|Dogs|Heart Rate|Lactates|Myocardial Contraction|Myocardium|Oxygen Consumption|Vasodilator Agents
pharmacology (0); therapeutic use (0)|drug therapy (1)||drug effects (0)||||drug effects (0)|metabolism (0)|drug effects (0)|metabolism (0)|drug effects (0)|pharmacology (1); therapeutic use (0)
0|0|0|0|0|0|0|0|0|0|0|0|0
null
1978-07-15
2019-09-02
pubmed: 1978-3-1; medline: 1978-3-1 0:1; entrez: 1978-3-1 0:0
pubmed: 13302471; doi: 10.1007/BF01906749
Myocardial Ischemia
['Angina Pectoris']
26,520
1
Comparison of the new beta-adrenoceptor antagonist, nadolol, and propranolol in the treatment of angina pectoris.
MEDLINE
Manual
NLM
A randomized, double-blind study was carried out in 24 patients with stable angina pectoris to compare the efficacy of nadolol, a new beta-adrenoceptor antagonist, and propranolol. After a period on placebo, 14 patients received nadolol once daily and 10 patients propranolol 4-times daily over a 10-week dose-ranging pe...
Current medical research and opinion
0300-7995
Print
5
5
Print
1,978
null
null
388-93
B Furberg (B); A Dahlqvist (A); A Raak (A); U Wrege (U)
Clinical Trial (D016430); Comparative Study (D003160); Journal Article (D016428); Randomized Controlled Trial (D016449)
Adrenergic beta-Antagonists (Registry: 0, UI: D000319); Placebos (Registry: 0, UI: D010919); Propranolol (Registry: 9Y8NXQ24VQ, UI: D011433); Nitroglycerin (Registry: G59M7S0WS3, UI: D005996)
Adrenergic beta-Antagonists (UI: D000319, Major: No) - Qualifiers: therapeutic use (UI: Q000627, Major: Yes); Adult (UI: D000328, Major: No); Aged (UI: D000368, Major: No); Angina Pectoris (UI: D000787, Major: No) - Qualifiers: drug therapy (UI: Q000188, Major: Yes); Clinical Trials as Topic (UI: D002986, Major: No); D...
Adrenergic beta-Antagonists|Adult|Aged|Angina Pectoris|Clinical Trials as Topic|Double-Blind Method|Female|Humans|Male|Middle Aged|Nitroglycerin|Physical Exertion|Placebos|Propranolol
therapeutic use (1)|||drug therapy (1)|||||||therapeutic use (0)|||therapeutic use (1)
0|0|0|0|0|0|0|0|0|0|0|0|0|0
null
1978-08-28
2019-09-07
pubmed: 1978-1-1; medline: 1978-1-1 0:1; entrez: 1978-1-1 0:0
pubmed: 26520; doi: 10.1185/03007997809111903
Myocardial Ischemia
['Angina Pectoris']
26,631
1
[Regional myocardial blood supply in coronary disease].
MEDLINE
Manual
NLM
1. Value and limitations of the precordial Xenon-clearance technique are analyzed. The results of this technique are compared to the scintigraphic display of the initial Xenon distribution and to microsphere scintigraphy (Engel et al. 1976a). 2. The effects of coronary obstructions and of segmental LV dysfunction on re...
Fortschritte der Medizin
0015-8178
Print
96
23
Print
1,978
Jun
15
1223-6
H J Engel (HJ)
English Abstract (D004740); Journal Article (D016428)
Adrenergic beta-Antagonists (Registry: 0, UI: D000319); Nitro Compounds (Registry: 0, UI: D009574); Vasodilator Agents (Registry: 0, UI: D014665); Xenon (Registry: 3H3U766W84, UI: D014978); Calcium (Registry: SY7Q814VUP, UI: D002118)
Adrenergic beta-Antagonists (UI: D000319, Major: No) - Qualifiers: therapeutic use (UI: Q000627, Major: No); Calcium (UI: D002118, Major: No) - Qualifiers: antagonists & inhibitors (UI: Q000037, Major: No); Coronary Angiography (UI: D017023, Major: No); Coronary Disease (UI: D003327, Major: No) - Qualifiers: drug thera...
Adrenergic beta-Antagonists|Calcium|Coronary Angiography|Coronary Disease|Coronary Vessels|Heart Ventricles|Humans|Nitro Compounds|Vasodilator Agents|Xenon
therapeutic use (0)|antagonists & inhibitors (0)||drug therapy (0); physiopathology (1)||physiopathology (0)||therapeutic use (0)|therapeutic use (0)|
0|0|0|0|1|0|0|0|0|0
null
1978-08-28
2015-11-19
pubmed: 1978-6-15; medline: 1978-6-15 0:1; entrez: 1978-6-15 0:0
pubmed: 26631
Myocardial Ischemia
['Coronary Disease']
26,669
1
Organic fluorides: implications for psychiatry.
MEDLINE
Manual
NLM
The widespread use of synthetic organic fluorides has recently received attention as a potential health hazard. There are a number of organic fluorides which have become important considerations in psychiatry. Therapeutically the organic fluorides include the neuroleptics trifluoperazine, fluphenazine, triflupromazine,...
The Journal of clinical psychiatry
0160-6689
Print
39
6
Print
1,978
Jun
null
523, 527-31
R W Guynn (RW); L A Faillace (LA)
Journal Article (D016428); Review (D016454)
Aerosols (Registry: 0, UI: D000336); Anti-Anxiety Agents (Registry: 0, UI: D014151); Fluoroacetates (Registry: 0, UI: D005463); Hydrocarbons, Fluorinated (Registry: 0, UI: D006845); Tranquilizing Agents (Registry: 0, UI: D014149); Benzodiazepines (Registry: 12794-10-4, UI: D001569); Flurothyl (Registry: 9Z467FG2YK, UI:...
Aerosols (UI: D000336, Major: No); Anesthesiology (UI: D000776, Major: No); Animals (UI: D000818, Major: No); Anti-Anxiety Agents (UI: D014151, Major: No) - Qualifiers: adverse effects (UI: Q000009, Major: No); Arrhythmias, Cardiac (UI: D001145, Major: No) - Qualifiers: chemically induced (UI: Q000139, Major: No); Benz...
Aerosols|Anesthesiology|Animals|Anti-Anxiety Agents|Arrhythmias, Cardiac|Benzodiazepines|Biotransformation|Bone and Bones|Cell Membrane|Chemical Phenomena|Chemical and Drug Induced Liver Injury|Chemistry|Drug Hypersensitivity|Environmental Exposure|Fluoroacetates|Fluorosis, Dental|Flurothyl|Humans|Hydrocarbons, Fluorin...
|||adverse effects (0)|chemically induced (0)|||drug effects (0)|drug effects (0)||etiology (0)||||toxicity (0)|etiology (0)|adverse effects (0)||adverse effects (0); metabolism (1)|drug effects (0)|||adverse effects (0)
0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0
null
1978-08-28
2016-11-23
pubmed: 1978-6-1; medline: 1978-6-1 0:1; entrez: 1978-6-1 0:0
pubmed: 26669
Arrhythmias, Cardiac
[]
26,795
1
Beta adrenergic blockade, regional left ventricular blood flow and ST-segment elevation in canine experimental myocardial ischemia.
MEDLINE
Manual
NLM
The effects of dl-propranolol, d-propranolol, dl-pindolol and dl-practolol on regional myocardial blood flow (assessed by means of tracer microspheres) and on ST-segment elevation in ischemic and nonischemic areas of the canine left ventricle have been investigated. dl-Propranolol and dl-pindolol, but not dl-practolol ...
The Journal of pharmacology and experimental therapeutics
0022-3565
Print
205
3
Print
1,978
Jun
null
646-56
A Berdeaux (A); C Peres da Costa (C); M Garnier (M); J R Boissier (JR); J F Giudicelli (JF)
Journal Article (D016428)
Adrenergic beta-Antagonists (Registry: 0, UI: D000319); Propranolol (Registry: 9Y8NXQ24VQ, UI: D011433); Pindolol (Registry: BJ4HF6IU1D, UI: D010869); Practolol (Registry: SUG9176GRW, UI: D011217)
Adrenergic beta-Antagonists (UI: D000319, Major: No) - Qualifiers: pharmacology (UI: Q000494, Major: Yes); Animals (UI: D000818, Major: No); Coronary Circulation (UI: D003326, Major: No) - Qualifiers: drug effects (UI: Q000187, Major: Yes); Dogs (UI: D004285, Major: No); Electrocardiography (UI: D004562, Major: Yes); F...
Adrenergic beta-Antagonists|Animals|Coronary Circulation|Dogs|Electrocardiography|Female|Hemodynamics|Male|Myocardial Infarction|Pindolol|Practolol|Propranolol|Stereoisomerism
pharmacology (1)||drug effects (1)||||drug effects (0)||physiopathology (1)|pharmacology (0)|pharmacology (0)|pharmacology (0)|
0|0|0|0|1|0|0|0|0|0|0|0|0
null
1978-08-28
2013-11-21
pubmed: 1978-6-1; medline: 1978-6-1 0:1; entrez: 1978-6-1 0:0
pubmed: 26795
Myocardial Ischemia
['Myocardial Infarction']
26,867
1
[Atrial tachycardia with atrio-ventricular block in infancy and childhood (author's transl)].
MEDLINE
Manual
NLM
Atrial tachycardia with atrio-ventricular block is a very rare arrhythmia in infancy and childhood. We saw ten patients between 3 days and fifteen years old. Six of them had a congenital heart disease, in four cases we could'nt find any cardiac or extracardiac illness. In every case digitalis intoxication was excluded....
Monatsschrift fur Kinderheilkunde
null
null
126
6
Print
1,978
Jun
null
387-90
D Wolf (D)
English Abstract (D004740); Journal Article (D016428)
Adrenergic beta-Antagonists (Registry: 0, UI: D000319); Digitalis Glycosides (Registry: 0, UI: D004071); Quinidine (Registry: ITX08688JL, UI: D011802)
Adrenergic beta-Antagonists (UI: D000319, Major: No) - Qualifiers: therapeutic use (UI: Q000627, Major: No); Child (UI: D002648, Major: No); Child, Preschool (UI: D002675, Major: No); Digitalis Glycosides (UI: D004071, Major: No) - Qualifiers: therapeutic use (UI: Q000627, Major: No); Electrocardiography (UI: D004562, ...
Adrenergic beta-Antagonists|Child|Child, Preschool|Digitalis Glycosides|Electrocardiography|Heart Atria|Heart Block|Heart Defects, Congenital|Humans|Infant|Quinidine|Tachycardia|Tachycardia, Paroxysmal
therapeutic use (0)|||therapeutic use (0)|||complications (1); diagnosis (0)|complications (0)|||therapeutic use (0)|complications (1); diagnosis (0); drug therapy (0)|complications (0)
0|0|0|0|0|0|0|0|0|0|0|0|0
null
1978-08-28
2014-07-29
pubmed: 1978-6-1; medline: 1978-6-1 0:1; entrez: 1978-6-1 0:0
pubmed: 26867
Arrhythmias, Cardiac
['Heart Block', 'Tachycardia']
27,127
1
[Changes of circulation, blood gases, acid-base-and metabolism during neurolept-analgesia with and without beta-receptor blockers in electro coagulation of Gasser's ganglion (author's transl)].
MEDLINE
Manual
NLM
The cardiovascular, blood gas, acid-base and metabolic changes occurring during operative stress were studied in 10 elderly, metabolically healthy patients, suffering from idiopathic trigeminal neuralgia, who underwent electrocoagulation of the gasserian ganglion under neuroleptanalgesia. In a group of 12 patients unde...
Der Anaesthesist
0003-2417
Print
27
5
Print
1,978
May
null
213-8
R Knitza (R); M Olbermann (M); F Fischer (F); K H Bässler (KH)
Clinical Trial (D016430); English Abstract (D004740); Journal Article (D016428); Randomized Controlled Trial (D016449)
Bicarbonates (Registry: 0, UI: D001639); Blood Glucose (Registry: 0, UI: D001786); Fatty Acids, Nonesterified (Registry: 0, UI: D005230); Ketone Bodies (Registry: 0, UI: D007657); Pindolol (Registry: BJ4HF6IU1D, UI: D010869); Glycerol (Registry: PDC6A3C0OX, UI: D005990)
Acid-Base Equilibrium (UI: D000136, Major: No) - Qualifiers: drug effects (UI: Q000187, Major: Yes); Aged (UI: D000368, Major: No); Bicarbonates (UI: D001639, Major: No) - Qualifiers: blood (UI: Q000097, Major: No); Blood Gas Analysis (UI: D001784, Major: Yes); Blood Glucose (UI: D001786, Major: No) - Qualifiers: analy...
Acid-Base Equilibrium|Aged|Bicarbonates|Blood Gas Analysis|Blood Glucose|Blood Pressure|Cardiovascular System|Electrocoagulation|Fatty Acids, Nonesterified|Female|Glycerol|Humans|Hydrogen-Ion Concentration|Ketone Bodies|Male|Metabolism|Middle Aged|Neuroleptanalgesia|Pindolol|Tachycardia|Trigeminal Nerve|Trigeminal Neur...
drug effects (1)||blood (0)||analysis (0)|drug effects (0)|drug effects (1)||blood (0)||blood (0)|||blood (0)||drug effects (1)|||pharmacology (1)|chemically induced (0)|surgery (1)|surgery (0)
0|0|0|1|0|0|0|1|0|0|0|0|0|0|0|0|0|1|0|0|0|0
null
1978-08-14
2013-11-21
pubmed: 1978-5-1; medline: 1978-5-1 0:1; entrez: 1978-5-1 0:0
pubmed: 27127
Arrhythmias, Cardiac
['Tachycardia']
27,149
1
[Nonspecific aorto-arteritis. Anatomo-pathological study of 18 cases].
MEDLINE
Manual
NLM
The present study comprises a pathological review of 18 necropsy cases with nonspecific aorto-arteritis (Takayasu's disease), autopsied at the Instituto Nacional de Cardiología of Mexico up to 1976. There were 11 females and 7 males with an average age at the time of death of 21.5 years. A comparison according to the d...
Archivos del Instituto de Cardiologia de Mexico
0020-3785
Print
48
1
Print
null
null
null
80-98
V G Renteria (VG); M Contreras (M)
English Abstract (D004740); Journal Article (D016428)
null
Adolescent (UI: D000293, Major: No); Adult (UI: D000328, Major: No); Aorta (UI: D001011, Major: No) - Qualifiers: pathology (UI: Q000473, Major: Yes); Aortic Arch Syndromes (UI: D001015, Major: No) - Qualifiers: pathology (UI: Q000473, Major: Yes); Child (UI: D002648, Major: No); Coronary Vessels (UI: D003331, Major: N...
Adolescent|Adult|Aorta|Aortic Arch Syndromes|Child|Coronary Vessels|Female|Humans|Male|Myocardial Infarction|Pulmonary Artery|Takayasu Arteritis
||pathology (1)|pathology (1)||pathology (1)||||etiology (0)|pathology (1)|complications (0); pathology (1)
0|0|0|0|0|0|0|0|0|0|0|0
null
1978-08-28
2007-11-15
pubmed: 1978-1-1; medline: 1978-1-1 0:1; entrez: 1978-1-1 0:0
pubmed: 27149
Myocardial Ischemia
['Myocardial Infarction']
27,156
1
[The myocardiopathies of dermatomyositis and periarteritis nodosa].
MEDLINE
Manual
NLM
Myocardial involvement was indicated by isolated findings (especially on the ECG) without corresponding functional disorders in one third of cases of dermatomyositis. Rapidly fatal heart failure occurred rarely in this disease, and was noteworthy for a QS complex in the central precordial leads, and for the presence of...
Archives des maladies du coeur et des vaisseaux
0003-9683
Print
71
4
Print
1,978
Apr
null
391-6
R Loire (R)
English Abstract (D004740); Journal Article (D016428)
null
Cardiomyopathies (UI: D009202, Major: Yes) - Qualifiers: complications (UI: Q000150, Major: No); pathology (UI: Q000473, Major: No); Coronary Disease (UI: D003327, Major: No) - Qualifiers: etiology (UI: Q000209, Major: No); Dermatomyositis (UI: D003882, Major: Yes) - Qualifiers: complications (UI: Q000150, Major: No); ...
Cardiomyopathies|Coronary Disease|Dermatomyositis|Heart Failure|Humans|Myocarditis|Myocardium|Polyarteritis Nodosa
complications (0); pathology (0)|etiology (0)|complications (0); pathology (0)|etiology (0)||etiology (0)|pathology (0)|complications (0); pathology (0)
1|0|1|0|0|0|0|1
null
1978-08-28
2009-02-13
pubmed: 1978-4-1; medline: 1978-4-1 0:1; entrez: 1978-4-1 0:0
pubmed: 27156
Myocardial Ischemia
['Coronary Disease']
27,430
1
[Psychopharmacologic drugs in the rehabilitation after myocardial infarct].
MEDLINE
Manual
NLM
The specific use of psychotropic agents in myocardial infarction has become possible due to interdisciplinary cooperation. Especially the differentiated therapeutic application of benzodiazepine derivatives will take into better account the different psychopathologic states in the various phases. The medicamentous faci...
Fortschritte der Medizin
0015-8178
Print
96
25
Print
1,978
Jul
6
1301-6
L Blaha (L); B Heerklotz (B)
English Abstract (D004740); Journal Article (D016428)
Adrenergic beta-Antagonists (Registry: 0, UI: D000319); Anti-Anxiety Agents (Registry: 0, UI: D014151); Antidepressive Agents (Registry: 0, UI: D000928); Psychotropic Drugs (Registry: 0, UI: D011619); Tranquilizing Agents (Registry: 0, UI: D014149); Benzodiazepines (Registry: 12794-10-4, UI: D001569)
Adrenergic beta-Antagonists (UI: D000319, Major: No) - Qualifiers: therapeutic use (UI: Q000627, Major: No); Anti-Anxiety Agents (UI: D014151, Major: No) - Qualifiers: therapeutic use (UI: Q000627, Major: No); Antidepressive Agents (UI: D000928, Major: No) - Qualifiers: therapeutic use (UI: Q000627, Major: No); Benzodi...
Adrenergic beta-Antagonists|Anti-Anxiety Agents|Antidepressive Agents|Benzodiazepines|Convalescence|Myocardial Infarction|Psychotropic Drugs|Tranquilizing Agents
therapeutic use (0)|therapeutic use (0)|therapeutic use (0)|||rehabilitation (1)|therapeutic use (1)|therapeutic use (0)
0|0|0|0|0|0|0|0
null
1978-09-15
2008-11-21
pubmed: 1978-7-6; medline: 1978-7-6 0:1; entrez: 1978-7-6 0:0
pubmed: 27430
Myocardial Ischemia
['Myocardial Infarction']
27,664
1
[Effect of adrenergic beta receptor blockaders on bronchial patency in ischemic heart disease].
MEDLINE
Manual
NLM
The effect of beta-adrenergic blocking agents inderal, trazicor, visken, benzoral and aptin on the bronchial patency was studied by means of four ventilation indices in 85 patients, 62 of whome had various diseases of the lungs; 44 of these patients had bronchial obstruction. It was established that all beta-blocking a...
Kardiologiia
0022-9040
Print
18
4
Print
1,978
Apr
null
106-9
L N Maksimova (LN); B L Sandomirskiĭ (BL)
Comparative Study (D003160); English Abstract (D004740); Journal Article (D016428)
Adrenergic beta-Antagonists (Registry: 0, UI: D000319); Oxprenolol (Registry: 519MXN9YZR, UI: D010096); Propranolol (Registry: 9Y8NXQ24VQ, UI: D011433); Pindolol (Registry: BJ4HF6IU1D, UI: D010869)
Adrenergic beta-Antagonists (UI: D000319, Major: No) - Qualifiers: adverse effects (UI: Q000009, Major: No); therapeutic use (UI: Q000627, Major: Yes); Bronchi (UI: D001980, Major: No) - Qualifiers: drug effects (UI: Q000187, Major: No); physiopathology (UI: Q000503, Major: Yes); Bronchial Spasm (UI: D001986, Major: No...
Adrenergic beta-Antagonists|Bronchi|Bronchial Spasm|Coronary Disease|Humans|Oxprenolol|Pindolol|Propranolol
adverse effects (0); therapeutic use (1)|drug effects (0); physiopathology (1)|chemically induced (0)|drug therapy (1); physiopathology (0)||therapeutic use (0)|therapeutic use (0)|therapeutic use (0)
0|0|0|0|0|0|0|0
null
1978-09-15
2017-03-10
pubmed: 1978-4-1; medline: 1978-4-1 0:1; entrez: 1978-4-1 0:0
pubmed: 27664
Myocardial Ischemia
['Coronary Disease']
27,710
1
[Disorder of porphyrin metabolism in thallium intoxication (author's transl)].
MEDLINE
Manual
NLM
A 19-year old male ingested in suicidal attempt 750 mg of thallium. He developed the characteristic symptoms of thallium intoxication. During the acute phase the urinary excretion of porphyrins and porphyrin precursors was largely increased. The percentage distribution of the individual metabolites of heme synthesis re...
Medizinische Klinik
0025-8458
Print
73
31
Print
1,978
Aug
4
1114-6
N Graben (N); M Doss (M); H A Klöppel (HA)
Case Reports (D002363); English Abstract (D004740); Journal Article (D016428)
Adrenergic beta-Antagonists (Registry: 0, UI: D000319); Antidotes (Registry: 0, UI: D000931); Ferric Compounds (Registry: 0, UI: D005290); Porphyrins (Registry: 0, UI: D011166); Thiosulfates (Registry: 0, UI: D013885); Thallium (Registry: AD84R52XLF, UI: D013793)
Adrenergic beta-Antagonists (UI: D000319, Major: No) - Qualifiers: therapeutic use (UI: Q000627, Major: No); Adult (UI: D000328, Major: No); Antidotes (UI: D000931, Major: No); Ferric Compounds (UI: D005290, Major: No) - Qualifiers: therapeutic use (UI: Q000627, Major: No); Humans (UI: D006801, Major: No); Hypotension ...
Adrenergic beta-Antagonists|Adult|Antidotes|Ferric Compounds|Humans|Hypotension|Male|Porphyrins|Renal Dialysis|Suicide|Tachycardia|Thallium|Thiosulfates
therapeutic use (0)|||therapeutic use (0)||chemically induced (0)||metabolism (1)|||chemically induced (0)|poisoning (1)|therapeutic use (0)
0|0|0|0|0|0|0|0|0|0|0|0|0
null
1978-09-25
2013-11-21
pubmed: 1978-8-4; medline: 2000-3-22 9:0; entrez: 1978-8-4 0:0
pubmed: 27710
Arrhythmias, Cardiac
['Tachycardia']
28,072
1
Response of left ventricular myocardial perfusion and cavity size to beta-blockade by acebutolol.
MEDLINE
Manual
NLM
The effect of beta-blockade by acebutolol on global and regional myocardial perfusion (133Xenon wash-out) was studied in 10 patients with coronary artery disease. Another group of 10 similar patients was used to study the effect of acebutolol on left ventricular cavity size (metal markers--spot film camera). Global per...
Annals of clinical research
0003-4762
Print
10
2
Print
1,978
Apr
null
66-70
M H Frick (MH); M Valle (M); O Korhola (O); P Hekali (P); E Riihimäki (E)
Journal Article (D016428)
Adrenergic beta-Antagonists (Registry: 0, UI: D000319); Xenon Radioisotopes (Registry: 0, UI: D014980); Acebutolol (Registry: 67P356D8GH, UI: D000070)
Acebutolol (UI: D000070, Major: No) - Qualifiers: pharmacology (UI: Q000494, Major: Yes); therapeutic use (UI: Q000627, Major: No); Adrenergic beta-Antagonists (UI: D000319, Major: No) - Qualifiers: therapeutic use (UI: Q000627, Major: No); Adult (UI: D000328, Major: No); Angina Pectoris (UI: D000787, Major: No) - Qual...
Acebutolol|Adrenergic beta-Antagonists|Adult|Angina Pectoris|Coronary Circulation|Heart Ventricles|Humans|Male|Middle Aged|Oxygen Consumption|Xenon Radioisotopes
pharmacology (1); therapeutic use (0)|therapeutic use (0)||drug therapy (0)|drug effects (1)|drug effects (0)||||drug effects (0)|
0|0|0|0|0|0|0|0|0|0|0
null
1978-09-29
2015-11-19
pubmed: 1978-4-1; medline: 1978-4-1 0:1; entrez: 1978-4-1 0:0
pubmed: 28072
Myocardial Ischemia
['Angina Pectoris']
28,231
1
Effects of stored and fresh blood transfusions on postoperative pulmonary function. A clinical study on patients following extracorporeal circulation in association with aortic valve surgery.
MEDLINE
Manual
NLM
The effects on postoperative pulmonary function of fresh versus stored blood when priming the heart-lung machine were studied in 49 patients subjected to aortic valvular replacement. The onset of extracorporeal circulation was considered to mimic the conditions of massive blood transfusion. The patients receiving hepar...
European surgical research. Europaische chirurgische Forschung. Recherches chirurgicales europeennes
0014-312X
Print
10
3
Print
1,978
null
null
153-64
B Brismar (B); B Gullbring (B); P Olsson (P)
Journal Article (D016428)
Carbon Dioxide (Registry: 142M471B3J, UI: D002245); Oxygen (Registry: S88TT14065, UI: D010100)
Aortic Valve (UI: D001021, Major: No) - Qualifiers: surgery (UI: Q000601, Major: Yes); Aortic Valve Insufficiency (UI: D001022, Major: No) - Qualifiers: surgery (UI: Q000601, Major: No); Aortic Valve Stenosis (UI: D001024, Major: No) - Qualifiers: surgery (UI: Q000601, Major: No); Blood (UI: D001769, Major: No); Blood ...
Aortic Valve|Aortic Valve Insufficiency|Aortic Valve Stenosis|Blood|Blood Preservation|Blood Transfusion|Carbon Dioxide|Extracorporeal Circulation|Heart Valve Prosthesis|Humans|Hydrogen-Ion Concentration|Oxygen|Partial Pressure|Postoperative Complications|Respiration|Respiration, Artificial
surgery (1)|surgery (0)|surgery (0)||||blood (0)|||||blood (0)||prevention & control (1)||
0|0|0|0|0|1|0|0|0|0|0|0|0|0|1|0
null
1978-10-27
2018-02-14
pubmed: 1978-1-1; medline: 1978-1-1 0:1; entrez: 1978-1-1 0:0
pubmed: 28231; doi: 10.1159/000128004
Heart Valve Diseases
['Aortic Valve Insufficiency', 'Aortic Valve Stenosis']
28,234
1
The influence of heart rate on ouabain cardiotoxicity in cats with spinal cord transection.
MEDLINE
Manual
NLM
The dose, serum level and ventricular content of ouabain needed to produce cardiotoxicity were examined in control cats, cats with transected spinal cords and cats with transected spinal cords whose heart rates were restored to control values by artificial pacing. The lethal dose of ouabain was higher in cats with tran...
European journal of pharmacology
0014-2999
Print
50
1
Print
1,978
Jul
1
69-74
N A Cagin (NA); J Somberg (J); E Freeman (E); H Bounous (H); A Raines (A); B Levitt (B)
Journal Article (D016428); Research Support, U.S. Gov't, P.H.S. (D013487)
Carbon Dioxide (Registry: 142M471B3J, UI: D002245); Ouabain (Registry: 5ACL011P69, UI: D010042); Oxygen (Registry: S88TT14065, UI: D010100)
Animals (UI: D000818, Major: No); Arrhythmias, Cardiac (UI: D001145, Major: No) - Qualifiers: chemically induced (UI: Q000139, Major: No); Blood Pressure (UI: D001794, Major: No) - Qualifiers: drug effects (UI: Q000187, Major: No); Carbon Dioxide (UI: D002245, Major: No) - Qualifiers: blood (UI: Q000097, Major: No); Ca...
Animals|Arrhythmias, Cardiac|Blood Pressure|Carbon Dioxide|Cats|Female|Heart Diseases|Heart Rate|Hydrogen-Ion Concentration|Male|Ouabain|Oxygen|Spinal Cord
|chemically induced (0)|drug effects (0)|blood (0)|||chemically induced (1)||||adverse effects (1)|blood (0)|physiology (1)
0|0|0|0|0|0|0|1|0|0|0|0|0
null
1978-10-18
2019-06-23
pubmed: 1978-7-1; medline: 1978-7-1 0:1; entrez: 1978-7-1 0:0
pubmed: 28234; pii: 0014-2999(78)90254-6; doi: 10.1016/0014-2999(78)90254-6
Arrhythmias, Cardiac
[]
28,610
1
[An inverse reaction of the ST-T complex in the elctrocardiogram due to beta receptor inhibition].
MEDLINE
Manual
NLM
In this article shall be referred to a special form of reaction of the ST-T-complexes in the propranolol test. Instead of a normalisation of this section of the ECG an inverse reaction develops. It consists in the fact that after application of propranolol the negativities of the T-waves increase and the lowerings of t...
Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete
0044-2542
Print
33
12
Print
1,978
Jun
15
395-9
F Polak (F)
English Abstract (D004740); Journal Article (D016428)
Adrenergic beta-Antagonists (Registry: 0, UI: D000319); Propranolol (Registry: 9Y8NXQ24VQ, UI: D011433)
Adrenergic beta-Antagonists (UI: D000319, Major: No) - Qualifiers: therapeutic use (UI: Q000627, Major: Yes); Angina Pectoris (UI: D000787, Major: No) - Qualifiers: drug therapy (UI: Q000188, Major: No); Arrhythmias, Cardiac (UI: D001145, Major: No) - Qualifiers: chemically induced (UI: Q000139, Major: Yes); Electrocar...
Adrenergic beta-Antagonists|Angina Pectoris|Arrhythmias, Cardiac|Electrocardiography|Heart Valve Diseases|Humans|Myocardial Infarction|Myocarditis|Propranolol
therapeutic use (1)|drug therapy (0)|chemically induced (1)||drug therapy (0)||drug therapy (0)|drug therapy (0)|therapeutic use (0)
0|0|0|0|0|0|0|0|0
null
1978-10-25
2013-11-21
pubmed: 1978-6-15; medline: 1978-6-15 0:1; entrez: 1978-6-15 0:0
pubmed: 28610
Myocardial Ischemia
['Angina Pectoris', 'Myocardial Infarction']
28,687
1
Effects of a new beta1-selective beta-blocker H 87/07 in angina pectoris.
MEDLINE
Manual
NLM
The efficacy and toleration of a new beta1-selective beta-blocker, H 87/07, was compared with placebo in 33 patients with angina pectoris. The efficacy was evaluated using subjective assessments of attack rate and nitroglycerin consumption as well as objective assessments of exercise tolerance on a bicycle ergometer. H...
Annals of clinical research
0003-4762
Print
9
5
Print
1,977
Oct
null
305-10
B Hedbäck (B); I Nordenfelt (I); B Svanström (B); A Vedin (A); C Wilhelmsson (C); K Oberg (K)
Clinical Trial (D016430); Controlled Clinical Trial (D018848); Journal Article (D016428); Randomized Controlled Trial (D016449)
Adrenergic beta-Antagonists (Registry: 0, UI: D000319); Nitroglycerin (Registry: G59M7S0WS3, UI: D005996)
Adrenergic beta-Antagonists (UI: D000319, Major: No) - Qualifiers: adverse effects (UI: Q000009, Major: No); blood (UI: Q000097, Major: No); therapeutic use (UI: Q000627, Major: Yes); Adult (UI: D000328, Major: No); Aged (UI: D000368, Major: No); Angina Pectoris (UI: D000787, Major: No) - Qualifiers: drug therapy (UI: ...
Adrenergic beta-Antagonists|Adult|Aged|Angina Pectoris|Blood Pressure|Clinical Trials as Topic|Drug Evaluation|Exercise Test|Female|Heart Failure|Heart Rate|Humans|Male|Middle Aged|Nitroglycerin
adverse effects (0); blood (0); therapeutic use (1)|||drug therapy (1)|drug effects (0)|||||chemically induced (0)|drug effects (0)||||administration & dosage (0); therapeutic use (0)
0|0|0|0|0|0|0|0|0|0|0|0|0|0|0
null
1978-10-27
2013-11-21
pubmed: 1977-10-1; medline: 1977-10-1 0:1; entrez: 1977-10-1 0:0
pubmed: 28687
Myocardial Ischemia
['Angina Pectoris']
28,709
1
[The atrial arrhythmia syndrome of vagal origin].
MEDLINE
Manual
NLM
Having observed 18 cases, the authors describe a syndrome of recurrent paroxysmal atrial arrhythmia which was very homogeneous from the clinical and ECG point of view. It was usually found in middle aged males, with no demonstrable underlying heart disease, whose disorder of intra-atrial conduction occurred during sinu...
Archives des maladies du coeur et des vaisseaux
0003-9683
Print
71
6
Print
1,978
Jun
null
645-56
P Coumel (P); P Attuel (P); J Lavallée (J); D Flammang (D); J F Leclercq (JF); R Slama (R)
English Abstract (D004740); Journal Article (D016428)
Adrenergic beta-Antagonists (Registry: 0, UI: D000319); Quinidine (Registry: ITX08688JL, UI: D011802); Amiodarone (Registry: N3RQ532IUT, UI: D000638)
Adrenergic beta-Antagonists (UI: D000319, Major: No) - Qualifiers: therapeutic use (UI: Q000627, Major: No); Adult (UI: D000328, Major: No); Amiodarone (UI: D000638, Major: No) - Qualifiers: therapeutic use (UI: Q000627, Major: No); Atrial Fibrillation (UI: D001281, Major: No) - Qualifiers: diagnosis (UI: Q000175, Majo...
Adrenergic beta-Antagonists|Adult|Amiodarone|Atrial Fibrillation|Atrial Flutter|Drug Resistance|Female|Humans|Male|Middle Aged|Pacemaker, Artificial|Quinidine|Vagus Nerve
therapeutic use (0)||therapeutic use (0)|diagnosis (0); etiology (1); therapy (0)|etiology (0)|||||||therapeutic use (0)|physiopathology (1)
0|0|0|0|0|0|0|0|0|0|0|0|0
null
1978-10-18
2013-11-21
pubmed: 1978-6-1; medline: 1978-6-1 0:1; entrez: 1978-6-1 0:0
pubmed: 28709
Arrhythmias, Cardiac
['Atrial Fibrillation', 'Atrial Flutter']
29,349
1
Clinical usefulness of the beta-adrenergic antagonists.
MEDLINE
Manual
NLM
The pharmacology of the beta-adrenergic antagonists, particularly their role as competitive antagonists at the receptor site, is discussed. The clinical use of these agents is listed and a detailed outline of their use in angina pectoris, hypertension and conditions associated with increased sympathetic activity is pro...
South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde
0256-9574
Print
54
4
Print
1,978
Jul
22
139-48
W F Lubbe (WF)
Journal Article (D016428); Review (D016454)
Adrenergic beta-Agonists (Registry: 0, UI: D000318); Adrenergic beta-Antagonists (Registry: 0, UI: D000319); Antihypertensive Agents (Registry: 0, UI: D000959); Propranolol (Registry: 9Y8NXQ24VQ, UI: D011433); Cyclic AMP (Registry: E0399OZS9N, UI: D000242); Isosorbide Dinitrate (Registry: IA7306519N, UI: D007548); Quin...
Adrenergic beta-Agonists (UI: D000318, Major: No) - Qualifiers: physiology (UI: Q000502, Major: No); Adrenergic beta-Antagonists (UI: D000319, Major: No) - Qualifiers: administration & dosage (UI: Q000008, Major: No); pharmacology (UI: Q000494, Major: Yes); physiology (UI: Q000502, Major: No); therapeutic use (UI: Q000...
Adrenergic beta-Agonists|Adrenergic beta-Antagonists|Angina Pectoris|Antihypertensive Agents|Anxiety|Arrhythmias, Cardiac|Atrial Fibrillation|Cardiomyopathy, Hypertrophic|Cell Communication|Cell Physiological Phenomena|Chemical Phenomena|Chemistry|Cyclic AMP|Drug Therapy, Combination|Epinephrine|Female|Humans|Hypertens...
physiology (0)|administration & dosage (0); pharmacology (1); physiology (0); therapeutic use (1)|drug therapy (0)|therapeutic use (0)|drug therapy (0)|drug therapy (0)|drug therapy (0)|drug therapy (0)|||||biosynthesis (0)||analogs & derivatives (0)|||drug therapy (0)|drug therapy (0)||therapeutic use (0)|drug therapy...
0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0
null
1978-12-02
2014-09-12
pubmed: 1978-7-22; medline: 1978-7-22 0:1; entrez: 1978-7-22 0:0
pubmed: 29349
Myocardial Ischemia
['Angina Pectoris', 'Myocardial Infarction']
29,354
1
Teratogenic action of bis(dichloroacetyl)diamine on rats: patterns of malformations produced in high incidence at time-limited periods of development.
MEDLINE
Manual
NLM
Win 18,446, a bis(dichloroacetyl)diamine, is a drug that was previously shown to suppress spermatogenesis and to be an effective oral abortifacient in rats. The present study shows that the drug is capable of producing characteristic congenital malformations in high incidence, by a single treatment, and with high survi...
Teratology
0040-3709
Print
18
1
Print
1,978
Aug
null
5-15
P Taleporos (P); M P Salgo (MP); G Oster (G)
Journal Article (D016428)
Diamines (Registry: 0, UI: D003959); Spermatogenesis-Blocking Agents (Registry: 0, UI: D013092); Teratogens (Registry: 0, UI: D013723)
Abnormalities, Drug-Induced (UI: D000014, Major: No) - Qualifiers: pathology (UI: Q000473, Major: Yes); Animals (UI: D000818, Major: No); Cryptorchidism (UI: D003456, Major: No) - Qualifiers: chemically induced (UI: Q000139, Major: No); Diamines (UI: D003959, Major: No) - Qualifiers: pharmacology (UI: Q000494, Major: N...
Abnormalities, Drug-Induced|Animals|Cryptorchidism|Diamines|Dose-Response Relationship, Drug|Female|Fetus|Gestational Age|Heart Septal Defects|Hernia, Diaphragmatic|Male|Pregnancy|Rats|Spermatogenesis-Blocking Agents|Teratogens|Thymus Gland
pathology (1)||chemically induced (0)|pharmacology (0); toxicity (1)|||pathology (1)||chemically induced (0)|chemically induced (0)||||pharmacology (0); toxicity (0)||abnormalities (0)
0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0
null
1978-11-18
2003-11-14
pubmed: 1978-8-1; medline: 1978-8-1 0:1; entrez: 1978-8-1 0:0
pubmed: 29354; doi: 10.1002/tera.1420180104
Heart Defects, Congenital
['Heart Septal Defects']
29,419
1
[Neurologic syndromes in myocardial infarct patients during various stages of treatment].
MEDLINE
Manual
NLM
The clinical picture of myocardial infarctions in complicated and manifold. A clinico-physiological analysis of neurological disorders gives ground to consider that in myocardial infarctions the process of irritation involves the peripheral vegetative apparatus and spinal segmental structures, as well as the hypothalmo...
Zhurnal nevropatologii i psikhiatrii imeni S.S. Korsakova (Moscow, Russia : 1952)
0044-4588
Print
78
8
Print
1,978
null
null
1149-54
V P Naĭdenov (VP)
English Abstract (D004740); Journal Article (D016428)
Ganglionic Blockers (Registry: 0, UI: D005730); Tranquilizing Agents (Registry: 0, UI: D014149)
Adult (UI: D000328, Major: No); Aged (UI: D000368, Major: No); Autonomic Nervous System (UI: D001341, Major: No); Female (UI: D005260, Major: No); Ganglionic Blockers (UI: D005730, Major: No) - Qualifiers: therapeutic use (UI: Q000627, Major: No); Horner Syndrome (UI: D006732, Major: No) - Qualifiers: diagnosis (UI: Q0...
Adult|Aged|Autonomic Nervous System|Female|Ganglionic Blockers|Horner Syndrome|Humans|Male|Middle Aged|Myocardial Infarction|Neurologic Manifestations|Polyneuropathies|Skin Manifestations|Spinal Nerve Roots|Stellate Ganglion|Syndrome|Tranquilizing Agents
||||therapeutic use (0)|diagnosis (0)||||diagnosis (1); drug therapy (0)||diagnosis (0)|||||therapeutic use (0)
0|0|0|0|0|0|0|0|0|0|1|0|0|0|0|0|0
null
1978-11-29
2006-11-15
pubmed: 1978-1-1; medline: 1978-1-1 0:1; entrez: 1978-1-1 0:0
pubmed: 29419
Myocardial Ischemia
['Myocardial Infarction']
29,482
1
Arterial hypoxemia following the administration of sublingual nitroglycerin.
MEDLINE
Manual
NLM
The effect of nitroglycerin on arterial blood gases and cardiovascular hemodynamics were studied in patients with coronary artery disease. In 13 premedicated patients blood gases and cardiovascular hemodynamics were studied before and 10 minutes after sublingual nitroglycerin (0.6 mg). In eight unpremedicated patients ...
American heart journal
0002-8703
Print
96
4
Print
1,978
Oct
null
444-7
E A Kopman (EA); G R Weygandt (GR); S Bauer (S); T B Ferguson (TB)
Journal Article (D016428)
Carbon Dioxide (Registry: 142M471B3J, UI: D002245); Nitroglycerin (Registry: G59M7S0WS3, UI: D005996); Oxygen (Registry: S88TT14065, UI: D010100)
Administration, Oral (UI: D000284, Major: No); Adult (UI: D000328, Major: No); Carbon Dioxide (UI: D002245, Major: No) - Qualifiers: blood (UI: Q000097, Major: No); Coronary Artery Bypass (UI: D001026, Major: No); Coronary Disease (UI: D003327, Major: No) - Qualifiers: drug therapy (UI: Q000188, Major: Yes); Female (UI...
Administration, Oral|Adult|Carbon Dioxide|Coronary Artery Bypass|Coronary Disease|Female|Hemodynamics|Humans|Hydrogen-Ion Concentration|Hypoxia|Male|Middle Aged|Nitroglycerin|Oxygen|Preanesthetic Medication
||blood (0)||drug therapy (1)||drug effects (0)|||chemically induced (1)|||administration & dosage (0); adverse effects (1); therapeutic use (0)|blood (0)|adverse effects (1)
0|0|0|0|0|0|0|0|0|0|0|0|0|0|0
null
1978-11-18
2019-06-26
pubmed: 1978-10-1; medline: 1978-10-1 0:1; entrez: 1978-10-1 0:0
pubmed: 29482; pii: 0002-8703(78)90153-9; doi: 10.1016/0002-8703(78)90153-9
Myocardial Ischemia
['Coronary Disease']
29,808
1
The pure gonadal dysgenesis syndrome.
MEDLINE
Manual
NLM
Two cases of gonadal dysgenesis in phenotypic females associated with different chromosomal patterns are discussed. Both patients presented with primary amenorrhea and were characterized by tall stature and underdeveloped secondary sex characteristics and external and internal reproductive organs. The karyotype of the ...
International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics
0020-7292
Print
15
6
Print
1,978
null
null
550-3
J A Fayez (JA)
Case Reports (D002363); Journal Article (D016428)
Estrogens (Registry: 0, UI: D004967)
Adolescent (UI: D000293, Major: No); Adult (UI: D000328, Major: No); Chromosomes, Human, 16-18 (UI: D002902, Major: No); Estrogens (UI: D004967, Major: No) - Qualifiers: therapeutic use (UI: Q000627, Major: No); Female (UI: D005260, Major: No); Gonads (UI: D006066, Major: No) - Qualifiers: pathology (UI: Q000473, Major...
Adolescent|Adult|Chromosomes, Human, 16-18|Estrogens|Female|Gonads|Humans|Karyotyping|Sex Chromosome Aberrations|Sex Chromosomes|Turner Syndrome
|||therapeutic use (0)||pathology (0)|||diagnosis (1)||diagnosis (1); drug therapy (0); pathology (0)
0|0|0|0|0|0|0|0|0|1|0
null
1978-12-29
2019-08-19
pubmed: 1978-1-1; medline: 1978-1-1 0:1; entrez: 1978-1-1 0:0
pubmed: 29808; doi: 10.1002/j.1879-3479.1977.tb00754.x
Heart Defects, Congenital
['Turner Syndrome']
29,982
1
[Gamma-glutamyl transpeptidase activity in ischemic heart disease].
MEDLINE
Manual
NLM
The blood plasma gamma-glutamyltranspeptidase (GGTP) activity was studied in 133 patients with macrofocal myocardial infarction, in 40 patients with microfocal myocardial infarction, in 30 patients with angina pectoris, and in 75 patients with cardiosclerosis and congestive cardiac failure. The activity of the enzyme i...
Kardiologiia
0022-9040
Print
18
9
Print
1,978
Sep
null
89-93
B Ia Bart (BIa)
English Abstract (D004740); Journal Article (D016428)
gamma-Glutamyltransferase (Registry: EC 2.3.2.2, UI: D005723)
Adult (UI: D000328, Major: No); Angina Pectoris (UI: D000787, Major: No) - Qualifiers: enzymology (UI: Q000201, Major: No); Coronary Disease (UI: D003327, Major: No) - Qualifiers: enzymology (UI: Q000201, Major: Yes); Enzyme Activation (UI: D004789, Major: No); Humans (UI: D006801, Major: No); Middle Aged (UI: D008875,...
Adult|Angina Pectoris|Coronary Disease|Enzyme Activation|Humans|Middle Aged|Myocardial Infarction|Time Factors|gamma-Glutamyltransferase
|enzymology (0)|enzymology (1)||||enzymology (0)||blood (1)
0|0|0|0|0|0|0|0|0
null
1978-12-27
2017-03-10
pubmed: 1978-9-1; medline: 1978-9-1 0:1; entrez: 1978-9-1 0:0
pubmed: 29982
Myocardial Ischemia
['Angina Pectoris', 'Coronary Disease', 'Myocardial Infarction']
29,995
1
Protection of the ischemic myocardium. Volume-duration relationships and the efficacy of myocardial infusates.
MEDLINE
Manual
NLM
In studies in the isolated rat heart that were designed to optimize the composition of the infusion conditions for a cardioplegic protective solutuin, we have observed a complex relationship between the duration and volume of infusion and the extent of tissue protection. Our results would indicate that solutions, such ...
The Journal of thoracic and cardiovascular surgery
0022-5223
Print
76
5
Print
1,978
Nov
null
698-705
P Jynge (P); D J Hearse (DJ); M V Braimbridge (MV)
Comparative Study (D003160); Journal Article (D016428)
Solutions (Registry: 0, UI: D012996); Mannitol (Registry: 3OWL53L36A, UI: D008353); Sodium Chloride (Registry: 451W47IQ8X, UI: D012965); Procaine (Registry: 4Z8Y51M438, UI: D011343); Potassium Chloride (Registry: 660YQ98I10, UI: D011189); Magnesium (Registry: I38ZP9992A, UI: D008274); Calcium Chloride (Registry: M4I0D6...
Animals (UI: D000818, Major: No); Calcium Chloride (UI: D002122, Major: No) - Qualifiers: administration & dosage (UI: Q000008, Major: No); Coronary Disease (UI: D003327, Major: No) - Qualifiers: prevention & control (UI: Q000517, Major: Yes); Drug Evaluation, Preclinical (UI: D004353, Major: No); Heart Arrest, Induced...
Animals|Calcium Chloride|Coronary Disease|Drug Evaluation, Preclinical|Heart Arrest, Induced|Hydrogen-Ion Concentration|Magnesium|Male|Mannitol|Osmolar Concentration|Potassium Chloride|Procaine|Rats|Sodium Chloride|Solutions
|administration & dosage (0)|prevention & control (1)||methods (1)||administration & dosage (0)||administration & dosage (0)||administration & dosage (0)|administration & dosage (0)||administration & dosage (0)|standards (1)
0|0|0|0|0|0|0|0|0|0|0|0|0|0|0
null
1978-12-20
2015-11-19
pubmed: 1978-11-1; medline: 1978-11-1 0:1; entrez: 1978-11-1 0:0
pubmed: 29995
Myocardial Ischemia
['Coronary Disease']
30,042
1
[Fenfluramin (ponderax) intoxications in children (author's transl)].
MEDLINE
Manual
NLM
4 cases of accidental fenfluramine poisoning in children are reported. Excitation, coma, convulsions, tachycardia, mydriasis, nystagmus, and rubeosis of the face were the most important signs. They appeared 30--60 min after ingestion, and some of them lasted for several days. 2 children had severe trismus and therefore...
Monatsschrift fur Kinderheilkunde
null
null
126
10
Print
1,978
Oct
null
631-5
K E Mühlendahl (KE); E G Krienke (EG)
Case Reports (D002363); English Abstract (D004740); Journal Article (D016428)
Adrenergic beta-Antagonists (Registry: 0, UI: D000319); Anticonvulsants (Registry: 0, UI: D000927); Fenfluramine (Registry: 2DS058H2CF, UI: D005277); Lidocaine (Registry: 98PI200987, UI: D008012); Chlorpromazine (Registry: U42B7VYA4P, UI: D002746)
Adolescent (UI: D000293, Major: No); Adrenergic beta-Antagonists (UI: D000319, Major: No) - Qualifiers: therapeutic use (UI: Q000627, Major: No); Anticonvulsants (UI: D000927, Major: No) - Qualifiers: therapeutic use (UI: Q000627, Major: No); Child, Preschool (UI: D002675, Major: No); Chlorpromazine (UI: D002746, Major...
Adolescent|Adrenergic beta-Antagonists|Anticonvulsants|Child, Preschool|Chlorpromazine|Coma|Electric Countershock|Female|Fenfluramine|Humans|Infant|Lidocaine|Male|Nystagmus, Pathologic|Respiration, Artificial|Seizures|Tachycardia|Time Factors
|therapeutic use (0)|therapeutic use (0)||therapeutic use (0)|chemically induced (0)|||poisoning (1)|||therapeutic use (0)||chemically induced (0)||chemically induced (0)|chemically induced (0)|
0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0
null
1978-12-20
2014-07-29
pubmed: 1978-10-1; medline: 1978-10-1 0:1; entrez: 1978-10-1 0:0
pubmed: 30042
Arrhythmias, Cardiac
['Tachycardia']
30,043
1
[Therapy with beta-blocking-agents (author's transl)].
MEDLINE
Manual
NLM
Within the last 10 years the indications for a therapeutic regimen with beta-blocking-agents have been differentiated: coronary heart disease with angina pectoris (interval regimen), essential hypertension, especially in younger persons; hyperkinetic heart syndrome; thyreotoxikosis, symptomatic therapy; heart rhythm di...
MMW, Munchener medizinische Wochenschrift
0341-3098
Print
120
44
Print
1,978
Nov
3
1461-6
H D Bolte (HD)
English Abstract (D004740); Journal Article (D016428)
Adrenergic beta-Antagonists (Registry: 0, UI: D000319)
Adrenergic beta-Antagonists (UI: D000319, Major: No) - Qualifiers: adverse effects (UI: Q000009, Major: No); therapeutic use (UI: Q000627, Major: Yes); Arrhythmias, Cardiac (UI: D001145, Major: No) - Qualifiers: drug therapy (UI: Q000188, Major: No); Bronchial Spasm (UI: D001986, Major: No) - Qualifiers: chemically ind...
Adrenergic beta-Antagonists|Arrhythmias, Cardiac|Bronchial Spasm|Cardiomyopathies|Coronary Disease|Dose-Response Relationship, Drug|Humans|Hypertension|Hyperthyroidism|Hypotension
adverse effects (0); therapeutic use (1)|drug therapy (0)|chemically induced (0)|chemically induced (0)|drug therapy (0)|||drug therapy (0)|drug therapy (0)|chemically induced (0)
0|0|0|0|0|0|0|0|0|0
null
1978-12-27
2007-11-15
pubmed: 1978-11-3; medline: 1978-11-3 0:1; entrez: 1978-11-3 0:0
pubmed: 30043
Myocardial Ischemia
['Coronary Disease']
30,250
1
Clinical restitution following cerebral ischemia in hypo-, normo- and hyperglycemic rats.
MEDLINE
Manual
NLM
Rats with different levels of blood glucose concentration were exposed to 10 min of complete brain ischemia achieved by compression of neck vessels by a pneumatic cuff. All normoglycemic rats survived the ischemic period and made the best clinical recovery. Hyperglycemic rats died within 12 h. Seizure activity was obse...
Acta neurologica Scandinavica
0001-6314
Print
58
1
Print
1,978
Jul
null
1-8
E Siemkowicz (E); A J Hansen (AJ)
Journal Article (D016428)
Blood Glucose (Registry: 0, UI: D001786)
Animals (UI: D000818, Major: No); Blood Glucose (UI: D001786, Major: No) - Qualifiers: analysis (UI: Q000032, Major: No); Brain (UI: D001921, Major: No) - Qualifiers: physiopathology (UI: Q000503, Major: No); Brain Ischemia (UI: D002545, Major: No) - Qualifiers: mortality (UI: Q000401, Major: No); physiopathology (UI: ...
Animals|Blood Glucose|Brain|Brain Ischemia|Hydrogen-Ion Concentration|Hyperglycemia|Hypoglycemia|Male|Partial Pressure|Rats
|analysis (0)|physiopathology (0)|mortality (0); physiopathology (1)||physiopathology (1)|physiopathology (1)|||
0|0|0|0|0|0|0|0|0|0
null
1978-12-20
2006-08-16
pubmed: 1978-7-1; medline: 1978-7-1 0:1; entrez: 1978-7-1 0:0
pubmed: 30250
Cerebrovascular Disorders
['Brain Ischemia']
30,324
1
[Survived brain infarction in old age - clinical and morphological findings. II. Risk factors (author's transl)].
MEDLINE
Manual
NLM
208 hospitalized patients, nearly 80 years old, were investigated because of risk factors and complicating diseases. Hypertension (58.2%), typical myocardial infarctions (37.2%) and diabetes (45.2%) were twice often as in our comparable cases without stroke. Corresponding we found signs of left ventricular hypertrophy ...
Aktuelle Gerontologie
0300-5704
Print
8
9
Print
1,978
Sep
null
459-69
H Zapfe (H); S Feldmann (S)
English Abstract (D004740); Journal Article (D016428)
null
Age Factors (UI: D000367, Major: No); Aged (UI: D000368, Major: No); Cardiovascular Diseases (UI: D002318, Major: No) - Qualifiers: complications (UI: Q000150, Major: No); Cerebral Infarction (UI: D002544, Major: No) - Qualifiers: diagnosis (UI: Q000175, Major: Yes); etiology (UI: Q000209, Major: No); mortality (UI: Q0...
Age Factors|Aged|Cardiovascular Diseases|Cerebral Infarction|Diabetes Complications|Female|Germany, West|Humans|Hypertension|Male|Myocardial Infarction|Risk
||complications (0)|diagnosis (1); etiology (0); mortality (0)|||||complications (0)||complications (0)|
0|0|0|0|0|0|0|0|0|0|0|0
null
1978-12-20
2006-11-15
pubmed: 1978-9-1; medline: 1978-9-1 0:1; entrez: 1978-9-1 0:0
pubmed: 30324
Myocardial Ischemia
['Myocardial Infarction']
30,388
1
A comparative study of three beta 1-adrenoreceptor blocking drugs with different degree of intrinsic stimulating activity (metoprolol, practolol and H 87/07) in patients with angina pectoris.
MEDLINE
Manual
NLM
Three beta1-selective beta-blocker (metoprolol, practolol and H 87/07) were compared in 29 patients with stable angina pectoris. The main pharmacological difference between the three beta-blockers was their intrinsic stimulating activity (I.S.A.), metoprolol being devoid of I.S.A., practolol having moderate I.S.A. and ...
Annals of clinical research
0003-4762
Print
10
4
Print
1,978
Aug
null
185-90
O Keyriläinen (O); A Uusitalo (A)
Clinical Trial (D016430); Comparative Study (D003160); Journal Article (D016428); Randomized Controlled Trial (D016449)
Adrenergic beta-Antagonists (Registry: 0, UI: D000319); Propanolamines (Registry: 0, UI: D011412); Metoprolol (Registry: GEB06NHM23, UI: D008790); Practolol (Registry: SUG9176GRW, UI: D011217)
Adrenergic beta-Antagonists (UI: D000319, Major: No) - Qualifiers: adverse effects (UI: Q000009, Major: No); pharmacology (UI: Q000494, Major: No); therapeutic use (UI: Q000627, Major: Yes); Angina Pectoris (UI: D000787, Major: No) - Qualifiers: drug therapy (UI: Q000188, Major: Yes); Blood Pressure (UI: D001794, Major...
Adrenergic beta-Antagonists|Angina Pectoris|Blood Pressure|Heart Rate|Humans|Metoprolol|Physical Exertion|Practolol|Propanolamines
adverse effects (0); pharmacology (0); therapeutic use (1)|drug therapy (1)|drug effects (0)|drug effects (0)||therapeutic use (0)||therapeutic use (0)|therapeutic use (1)
0|0|0|0|0|0|0|0|0
null
1978-12-29
2013-11-21
pubmed: 1978-8-1; medline: 1978-8-1 0:1; entrez: 1978-8-1 0:0
pubmed: 30388
Myocardial Ischemia
['Angina Pectoris']
30,439
1
Myocardial infarction--the problems and prognosis: Paper 1.
MEDLINE
Manual
NLM
Deaths from coronary heart disease and myocardial infarct may occur in previously undiagnosed subjects (the so called pre-hospital phase), in hospital following admission to a coronary care unit, or following discharge. Mortality in the pre-hospital phase has been estimated at 35--40 per cent. Within Australia the mort...
Australian family physician
0300-8495
Print
Suppl
null
Print
1,978
Jun
null
11-5
J B Hickie (JB)
Journal Article (D016428)
Adrenergic beta-Antagonists (Registry: 0, UI: D000319); Anti-Arrhythmia Agents (Registry: 0, UI: D000889)
Adrenergic beta-Antagonists (UI: D000319, Major: No) - Qualifiers: therapeutic use (UI: Q000627, Major: No); Angiography (UI: D000792, Major: No); Anti-Arrhythmia Agents (UI: D000889, Major: No) - Qualifiers: therapeutic use (UI: Q000627, Major: No); Australia (UI: D001315, Major: No); Coronary Care Units (UI: D003325,...
Adrenergic beta-Antagonists|Angiography|Anti-Arrhythmia Agents|Australia|Coronary Care Units|Coronary Disease|Coronary Vessels|Hospitalization|Humans|Myocardial Infarction|Oxygen Consumption|Prognosis|Thrombosis
therapeutic use (0)||therapeutic use (0)|||surgery (0)||||blood (0); complications (0); diagnostic imaging (0); drug therapy (0); mortality (1)|||etiology (0)
0|0|0|0|0|0|0|0|0|0|0|0|0
null
1978-12-20
2016-11-23
pubmed: 1978-6-1; medline: 1978-6-1 0:1; entrez: 1978-6-1 0:0
pubmed: 30439
Myocardial Ischemia
['Coronary Disease', 'Myocardial Infarction']
30,442
1
The role of long term beta-blockade after myocardial infarction: Paper 2.
MEDLINE
Manual
NLM
Acute myocardial infarction is associated with pain, tissue damage and circulatory impairment. As a result of these changes, there is increased sympathetic drive to the heart in the form of increased sympathetic nerve activity and increased circulating catecholamines.
Australian family physician
0300-8495
Print
Suppl
null
Print
1,978
Jun
null
34-7
M Rosenbaum (M)
Journal Article (D016428)
Adrenergic beta-Antagonists (Registry: 0, UI: D000319)
Acute Disease (UI: D000208, Major: No); Administration, Oral (UI: D000284, Major: No); Adrenergic beta-Antagonists (UI: D000319, Major: No) - Qualifiers: administration & dosage (UI: Q000008, Major: No); therapeutic use (UI: Q000627, Major: Yes); Animals (UI: D000818, Major: No); Arrhythmias, Cardiac (UI: D001145, Majo...
Acute Disease|Administration, Oral|Adrenergic beta-Antagonists|Animals|Arrhythmias, Cardiac|Death, Sudden|Humans|Injections, Intravenous|Myocardial Infarction|Prognosis|Time Factors
||administration & dosage (0); therapeutic use (1)||prevention & control (0)|prevention & control (0)|||drug therapy (1)||
0|0|0|0|0|0|0|0|0|0|0
null
1978-12-20
2007-11-15
pubmed: 1978-6-1; medline: 1978-6-1 0:1; entrez: 1978-6-1 0:0
pubmed: 30442
Myocardial Ischemia
['Myocardial Infarction']
30,440
1
Factors influencing the infarct: the place of beta-blockade in limiting infarct size.
MEDLINE
Manual
NLM
The mechanisms whereby myocardial infarction in man is precipitated are not understood--largely because the event is usually well established by the time medical help is called, but also because the techniques available have not yet permitted analysis of the earliest changes. On the other hand, the consequences of myoc...
Australian family physician
0300-8495
Print
Suppl
null
Print
1,978
Jun
null
27-31
M Thomas (M)
Journal Article (D016428)
Adrenergic beta-Antagonists (Registry: 0, UI: D000319); Creatine Kinase (Registry: EC 2.7.3.2, UI: D003402); Practolol (Registry: SUG9176GRW, UI: D011217)
Adrenergic beta-Antagonists (UI: D000319, Major: No) - Qualifiers: therapeutic use (UI: Q000627, Major: Yes); Creatine Kinase (UI: D003402, Major: No) - Qualifiers: analysis (UI: Q000032, Major: No); Humans (UI: D006801, Major: No); Myocardial Infarction (UI: D009203, Major: No) - Qualifiers: drug therapy (UI: Q000188,...
Adrenergic beta-Antagonists|Creatine Kinase|Humans|Myocardial Infarction|Practolol|Rest
therapeutic use (1)|analysis (0)||drug therapy (1); enzymology (0); therapy (0)|therapeutic use (0)|
0|0|0|0|0|0
null
1978-12-20
2013-11-21
pubmed: 1978-6-1; medline: 1978-6-1 0:1; entrez: 1978-6-1 0:0
pubmed: 30440
Myocardial Ischemia
['Myocardial Infarction']
30,441
1
The role of long term beta-blockade after myocardial infarction: Paper 1.
MEDLINE
Manual
NLM
The opinion is emerging that beta-blocking drugs have an important role in management of patients following acute myocardial infarction. Already beta-blocking drugs are accepted as the treatment of choice in hypertension and in angina pectoris--in the major risk factor and consequence respectively of coronary atheroscl...
Australian family physician
0300-8495
Print
Suppl
null
Print
1,978
Jun
null
32-3
M O'Rourke (M)
Journal Article (D016428)
Adrenergic beta-Antagonists (Registry: 0, UI: D000319)
Acute Disease (UI: D000208, Major: No); Adrenergic beta-Antagonists (UI: D000319, Major: No) - Qualifiers: therapeutic use (UI: Q000627, Major: Yes); Death, Sudden (UI: D003645, Major: No) - Qualifiers: prevention & control (UI: Q000517, Major: No); Humans (UI: D006801, Major: No); Myocardial Infarction (UI: D009203, M...
Acute Disease|Adrenergic beta-Antagonists|Death, Sudden|Humans|Myocardial Infarction|Time Factors
|therapeutic use (1)|prevention & control (0)||drug therapy (1)|
0|0|0|0|0|0
null
1978-12-20
2004-11-17
pubmed: 1978-6-1; medline: 1978-6-1 0:1; entrez: 1978-6-1 0:0
pubmed: 30441
Myocardial Ischemia
['Myocardial Infarction']
30,443
1
The role of long term beta-blockade after myocardial infarction: Paper 3.
MEDLINE
Manual
NLM
For many years the search has gone on for suitable drug therapy to improve survival following myocardial infarction. Most recently, beta-adrenergic blockade has entered the lists. Naturally beta-blockade is used in the conventional way to combat angina pectoris following an infarct, and one can expect that 70 per cent ...
Australian family physician
0300-8495
Print
Suppl
null
Print
1,978
Jun
null
38-9
R K Wilkinson (RK)
Journal Article (D016428)
Adrenergic beta-Antagonists (Registry: 0, UI: D000319); Alprenolol (Registry: 877K5MQ27W, UI: D000526); Practolol (Registry: SUG9176GRW, UI: D011217)
Adrenergic beta-Antagonists (UI: D000319, Major: No) - Qualifiers: therapeutic use (UI: Q000627, Major: Yes); Alprenolol (UI: D000526, Major: No) - Qualifiers: therapeutic use (UI: Q000627, Major: No); Angina Pectoris (UI: D000787, Major: No) - Qualifiers: drug therapy (UI: Q000188, Major: No); Humans (UI: D006801, Maj...
Adrenergic beta-Antagonists|Alprenolol|Angina Pectoris|Humans|Myocardial Infarction|Practolol|Time Factors
therapeutic use (1)|therapeutic use (0)|drug therapy (0)||drug therapy (1)|therapeutic use (0)|
0|0|0|0|0|0|0
null
1978-12-20
2013-11-21
pubmed: 1978-6-1; medline: 1978-6-1 0:1; entrez: 1978-6-1 0:0
pubmed: 30443
Myocardial Ischemia
['Angina Pectoris', 'Myocardial Infarction']
30,444
1
The role of long term beta-blockade after myocardial infarction: Paper 4.
MEDLINE
Manual
NLM
The place of beta-blockade following myocardial infarction should be considered in two phases; the acute infarction, and the long term management after infarction.
Australian family physician
0300-8495
Print
Suppl
null
Print
1,978
Jun
null
40-52
J S Robinson (JS)
Journal Article (D016428)
Adrenergic beta-Antagonists (Registry: 0, UI: D000319)
Acute Disease (UI: D000208, Major: No); Adrenergic beta-Antagonists (UI: D000319, Major: No) - Qualifiers: therapeutic use (UI: Q000627, Major: Yes); Angina Pectoris (UI: D000787, Major: No) - Qualifiers: drug therapy (UI: Q000188, Major: No); Death, Sudden (UI: D003645, Major: No) - Qualifiers: prevention & control (U...
Acute Disease|Adrenergic beta-Antagonists|Angina Pectoris|Death, Sudden|Humans|Hypertension|Myocardial Infarction|Time Factors
|therapeutic use (1)|drug therapy (0)|prevention & control (0)||drug therapy (0)|drug therapy (1)|
0|0|0|0|0|0|0|0
null
1978-12-20
2004-11-17
pubmed: 1978-6-1; medline: 1978-6-1 0:1; entrez: 1978-6-1 0:0
pubmed: 30444
Myocardial Ischemia
['Angina Pectoris', 'Myocardial Infarction']
30,564
1
Physostigmine for cardiac and neurologic manifestations of phenothiazine poisoning.
MEDLINE
Manual
NLM
Psychotropic drugs such as the phenothiazine neuroleptics and tricyclic antidepressants are known to cause electrocardiographic abnormalities as well as a central anticholinergic syndrome. Physostigmine is known to reverse the central muscarinic anticholinergic manifestations by inhibition of the enzyme cholinesterase....
Clinical pharmacology and therapeutics
0009-9236
Print
24
6
Print
1,978
Dec
null
663-7
D Weisdorf (D); J Kramer (J); A Goldbarg (A); H L Klawans (HL)
Case Reports (D002363); Journal Article (D016428)
Antipsychotic Agents (Registry: 0, UI: D014150); Parasympatholytics (Registry: 0, UI: D010276); Trifluoperazine (Registry: 214IZI85K3, UI: D014268); Physostigmine (Registry: 9U1VM840SP, UI: D010830)
Antipsychotic Agents (UI: D014150, Major: No) - Qualifiers: poisoning (UI: Q000506, Major: Yes); Arrhythmias, Cardiac (UI: D001145, Major: No) - Qualifiers: chemically induced (UI: Q000139, Major: No); drug therapy (UI: Q000188, Major: Yes); Electrocardiography (UI: D004562, Major: No); Humans (UI: D006801, Major: No);...
Antipsychotic Agents|Arrhythmias, Cardiac|Electrocardiography|Humans|Male|Middle Aged|Nervous System Diseases|Parasympatholytics|Physostigmine|Trifluoperazine
poisoning (1)|chemically induced (0); drug therapy (1)|||||chemically induced (0); drug therapy (1)|poisoning (0)|therapeutic use (1)|poisoning (0)
0|0|0|0|0|0|0|0|0|0
null
1979-01-26
2019-05-09
pubmed: 1978-12-1; medline: 1978-12-1 0:1; entrez: 1978-12-1 0:0
pubmed: 30564; doi: 10.1002/cpt1978246663
Arrhythmias, Cardiac
[]
30,738
1
[The hypertrophic obstructive cardiomyopathy (HOCM) of the newborn].
MEDLINE
Manual
NLM
A case of a newborn infant with clinical and angiocardiographic signs of hypertrophic obstructive cardiomyopathy (HOCM) is presented. The baby died after a short therapy with beta-blockers. Light- and electron-microscopic investigations showed severe disorganization of muscular cellular arrangement and disturbances of ...
Helvetica paediatrica acta
0018-022X
Print
33
3
Print
1,978
Aug
null
275-88
A Beitzke (A); L Auböck (L); H Becker (H); M Zach (M)
Case Reports (D002363); English Abstract (D004740); Journal Article (D016428)
Adrenergic beta-Antagonists (Registry: 0, UI: D000319)
Adrenergic beta-Antagonists (UI: D000319, Major: No) - Qualifiers: therapeutic use (UI: Q000627, Major: No); Cardiomyopathy, Hypertrophic (UI: D002312, Major: No) - Qualifiers: pathology (UI: Q000473, Major: Yes); Humans (UI: D006801, Major: No); Infant, Newborn (UI: D007231, Major: No); Infant, Newborn, Diseases (UI: ...
Adrenergic beta-Antagonists|Cardiomyopathy, Hypertrophic|Humans|Infant, Newborn|Infant, Newborn, Diseases|Male|Mitochondria, Heart|Myocardium
therapeutic use (0)|pathology (1)|||pathology (1)|||ultrastructure (0)
0|0|0|0|0|0|0|0
null
1979-01-15
2006-11-15
pubmed: 1978-8-1; medline: 1978-8-1 0:1; entrez: 1978-8-1 0:0
pubmed: 30738
Cardiomyopathies
['Cardiomyopathy, Hypertrophic']
30,853
1
[Comparative characteristics of various anti-arrhythmia agents used under clinical conditions].
MEDLINE
Manual
NLM
Comparative clinical and experimental study of the efficacy of the currently used anti-arrhythmic agents was conducted on 610 patients (828 cases) with various disorders of the cardiac rhythm. The modern classification of these agents is given. The indications and contra-indications for the prescription of the drugs, t...
Kardiologiia
0022-9040
Print
18
10
Print
1,978
Oct
null
30-7
I P Zamotaev (IP); L G Loziskiĭ (LG); B L Sandomirskiĭ (BL); M G Venediktova (MG)
Comparative Study (D003160); English Abstract (D004740); Journal Article (D016428)
Adrenergic beta-Antagonists (Registry: 0, UI: D000319); Anti-Arrhythmia Agents (Registry: 0, UI: D000889); Lidocaine (Registry: 98PI200987, UI: D008012); Quinidine (Registry: ITX08688JL, UI: D011802); Procainamide (Registry: L39WTC366D, UI: D011342); Metipranolol (Registry: X39AL81KEB, UI: D014290)
Administration, Oral (UI: D000284, Major: No); Adolescent (UI: D000293, Major: No); Adrenergic beta-Antagonists (UI: D000319, Major: No) - Qualifiers: administration & dosage (UI: Q000008, Major: No); therapeutic use (UI: Q000627, Major: Yes); Adult (UI: D000328, Major: No); Aged (UI: D000368, Major: No); Anti-Arrhythm...
Administration, Oral|Adolescent|Adrenergic beta-Antagonists|Adult|Aged|Anti-Arrhythmia Agents|Arrhythmias, Cardiac|Drug Evaluation|Humans|Injections, Intravenous|Lidocaine|Metipranolol|Middle Aged|Procainamide|Quinidine
||administration & dosage (0); therapeutic use (1)|||administration & dosage (0); therapeutic use (1)|drug therapy (1)||||administration & dosage (0); therapeutic use (0)|administration & dosage (0); therapeutic use (0)||administration & dosage (0); therapeutic use (0)|administration & dosage (0); therapeutic use (0)
0|0|0|0|0|0|0|0|0|0|0|0|0|0|0
null
1979-01-26
2017-03-10
pubmed: 1978-10-1; medline: 1978-10-1 0:1; entrez: 1978-10-1 0:0
pubmed: 30853
Arrhythmias, Cardiac
[]
31,115
1
[Thrombolytic treatment (theoretical basis, therapeutic protocols, monitoring)].
MEDLINE
Manual
NLM
Thrombolytic therapy is aimed at dissolving thrombi. Streptokinase (SK) and urokinase (UK) are currently used in France but their mode of action has not been completely elucidated, which renders the establishment of therapeutic protocols and the choice of doses difficult. This treatment has a certain number of contrain...
Annales de l'anesthesiologie francaise
0003-4061
Print
19
8
Print
1,978
null
null
711-9
J Conard (J); M Samama (M)
English Abstract (D004740); Journal Article (D016428)
Fibrinolytic Agents (Registry: 0, UI: D005343); Streptokinase (Registry: EC 3.4.-, UI: D013300); Fibrinolysin (Registry: EC 3.4.21.7, UI: D005341); Urokinase-Type Plasminogen Activator (Registry: EC 3.4.21.73, UI: D014568)
Arterial Occlusive Diseases (UI: D001157, Major: No) - Qualifiers: drug therapy (UI: Q000188, Major: No); Drug Hypersensitivity (UI: D004342, Major: No); Fibrinolysin (UI: D005341, Major: No) - Qualifiers: therapeutic use (UI: Q000627, Major: No); Fibrinolytic Agents (UI: D005343, Major: No) - Qualifiers: administratio...
Arterial Occlusive Diseases|Drug Hypersensitivity|Fibrinolysin|Fibrinolytic Agents|Hemorrhage|Humans|Myocardial Infarction|Pulmonary Embolism|Streptokinase|Thromboembolism|Thrombophlebitis|Urokinase-Type Plasminogen Activator
drug therapy (0)||therapeutic use (0)|administration & dosage (0); adverse effects (0); therapeutic use (1)|chemically induced (0)||drug therapy (0)|drug therapy (0)|therapeutic use (0)|drug therapy (1)|drug therapy (0)|therapeutic use (0)
0|0|0|0|0|0|0|0|0|0|0|0
null
1979-01-26
2009-11-19
pubmed: 1978-1-1; medline: 1978-1-1 0:1; entrez: 1978-1-1 0:0
pubmed: 31115
Myocardial Ischemia
['Myocardial Infarction']
31,117
1
[The treatment of myocardial infarct with streptokinase].
MEDLINE
Manual
NLM
The current situation concerning the use of Streptokinase in the treatment of recent myocardial infarction does not make it possible to draw any definite conclusions with regard to its therapeutic value:--mortality would not appear to be significantly modified in the majority of series;--the occurrence rate of major co...
Annales de l'anesthesiologie francaise
0003-4061
Print
19
8
Print
1,978
null
null
727-33
P E Valere (PE); R Tricot (R)
Clinical Trial (D016430); English Abstract (D004740); Journal Article (D016428)
Streptokinase (Registry: EC 3.4.-, UI: D013300)
Blood Viscosity (UI: D001809, Major: No) - Qualifiers: drug effects (UI: Q000187, Major: No); Clinical Trials as Topic (UI: D002986, Major: No); Drug Evaluation (UI: D004341, Major: No); Drug Tolerance (UI: D004361, Major: No); Heart Rupture (UI: D006341, Major: No) - Qualifiers: chemically induced (UI: Q000139, Major:...
Blood Viscosity|Clinical Trials as Topic|Drug Evaluation|Drug Tolerance|Heart Rupture|Hemorrhage|Humans|Intensive Care Units|Myocardial Infarction|Streptokinase
drug effects (0)||||chemically induced (0)|chemically induced (0)|||drug therapy (1); mortality (0)|adverse effects (0); therapeutic use (1)
0|0|0|0|0|0|0|0|0|0
null
1979-01-26
2007-11-15
pubmed: 1978-1-1; medline: 1978-1-1 0:1; entrez: 1978-1-1 0:0
pubmed: 31117
Myocardial Ischemia
['Myocardial Infarction']
31,118
1
[Moderate doses of urokinase (UK) in the treatment of myocardial infarct and pulmonary embolism].
MEDLINE
Manual
NLM
Since 1972, UK in moderate doses have been used in the treatment of severe or massive pulmonary emboli (PE) and of myocardial infarction (MI) present for less than 24 hours. The standard dose is 2,700,000 CTA units per 24 hours administered as a continuous infusion, in association with appropriate heparin therapy and a...
Annales de l'anesthesiologie francaise
0003-4061
Print
19
8
Print
1,978
null
null
735-8
M Brochier (M)
Clinical Trial (D016430); English Abstract (D004740); Journal Article (D016428); Randomized Controlled Trial (D016449)
Heparin (Registry: 9005-49-6, UI: D006493); Endopeptidases (Registry: EC 3.4.-, UI: D010450); Urokinase-Type Plasminogen Activator (Registry: EC 3.4.21.73, UI: D014568)
Clinical Trials as Topic (UI: D002986, Major: No); Dose-Response Relationship, Drug (UI: D004305, Major: No); Drug Evaluation (UI: D004341, Major: No); Drug Therapy, Combination (UI: D004359, Major: No); Endopeptidases (UI: D010450, Major: No) - Qualifiers: administration & dosage (UI: Q000008, Major: Yes); Heparin (UI...
Clinical Trials as Topic|Dose-Response Relationship, Drug|Drug Evaluation|Drug Therapy, Combination|Endopeptidases|Heparin|Humans|Myocardial Infarction|Pulmonary Embolism|Urokinase-Type Plasminogen Activator
||||administration & dosage (1)|administration & dosage (0)||drug therapy (1)|drug therapy (1)|administration & dosage (1)
0|0|0|0|0|0|0|0|0|0
null
1979-01-26
2008-11-21
pubmed: 1978-1-1; medline: 1978-1-1 0:1; entrez: 1978-1-1 0:0
pubmed: 31118
Myocardial Ischemia
['Myocardial Infarction']
31,282
1
Cardiac lesions induced by chemicals.
MEDLINE
Manual
NLM
Chemically induced cardiomyopathies are frequently the consequences of a cardiac metabolic imbalance brought about by exaggerated functional affects. The infarctlike lesions induced by adrenergic beta-receptor stimulants and the vasodilating antihypertensives serve as examples of this phenomenon. Direct cardiotoxic mec...
Environmental health perspectives
0091-6765
Print
26
null
Print
1,978
Oct
null
181-91
T Balazs (T); V J Ferrans (VJ)
Journal Article (D016428); Review (D016454)
Adrenergic beta-Agonists (Registry: 0, UI: D000318); Antihypertensive Agents (Registry: 0, UI: D000959); Doxorubicin (Registry: 80168379AG, UI: D004317); Daunorubicin (Registry: ZS7284E0ZP, UI: D003630)
Acute Disease (UI: D000208, Major: No); Adrenergic beta-Agonists (UI: D000318, Major: No) - Qualifiers: adverse effects (UI: Q000009, Major: No); Animals (UI: D000818, Major: No); Antihypertensive Agents (UI: D000959, Major: No) - Qualifiers: adverse effects (UI: Q000009, Major: No); Cardiomyopathies (UI: D009202, Majo...
Acute Disease|Adrenergic beta-Agonists|Animals|Antihypertensive Agents|Cardiomyopathies|Cardiovascular System|Chronic Disease|Daunorubicin|Doxorubicin|Drug Evaluation, Preclinical|Heart Diseases|Humans|Species Specificity
|adverse effects (0)||adverse effects (0)|chemically induced (0); pathology (0)|drug effects (0)||adverse effects (0)|adverse effects (0)||chemically induced (1); pathology (0)||
0|0|0|0|0|0|0|0|0|0|0|0|0
null
1979-02-21
2018-11-13
pubmed: 1978-10-1; medline: 1978-10-1 0:1; entrez: 1978-10-1 0:0
pubmed: 135884; pmc: PMC1637252; doi: 10.1289/ehp.7826181
Cardiomyopathies
[]
31,419
1
Induced hypotension for orthognathic surgery.
MEDLINE
Manual
NLM
Achieving satisfactory hemostasis during orthognathic surgery may be difficult because of the extensive vascularity of facial structures. Hypotensive anesthetic techniques provide clear operative fields by altering regional tissue perfusion through the use of systemic vasodilators, ganglionic blocking agents, and posit...
Journal of oral surgery (American Dental Association : 1965)
0022-3255
Print
37
1
Print
1,979
Jan
null
47-51
D M Gallagher (DM); R A Milliken (RA)
Journal Article (D016428)
Bis-Trimethylammonium Compounds (Registry: 0, UI: D008725); Cyanides (Registry: 0, UI: D003486); Ganglionic Blockers (Registry: 0, UI: D005730); Nitroprusside (Registry: 169D1260KM, UI: D009599); Trimethaphan (Registry: 6G8X656T45, UI: D014294); Enflurane (Registry: 91I69L5AY5, UI: D004737); Halothane (Registry: UQT9G4...
Adult (UI: D000328, Major: No); Bis-Trimethylammonium Compounds (UI: D008725, Major: No) - Qualifiers: therapeutic use (UI: Q000627, Major: No); Blood Pressure (UI: D001794, Major: No) - Qualifiers: drug effects (UI: Q000187, Major: No); Body Temperature (UI: D001831, Major: No); Cyanides (UI: D003486, Major: No) - Qua...
Adult|Bis-Trimethylammonium Compounds|Blood Pressure|Body Temperature|Cyanides|Enflurane|Ganglionic Blockers|Halothane|Hemodynamics|Hemostasis, Surgical|Humans|Hypotension, Controlled|Monitoring, Physiologic|Nitroprusside|Orthognathic Surgical Procedures|Osteotomy|Positive-Pressure Respiration|Posture|Tachycardia|Time ...
|therapeutic use (0)|drug effects (0)||blood (0)|therapeutic use (0)|pharmacology (0); therapeutic use (0)|therapeutic use (0)||||adverse effects (0)||adverse effects (0); pharmacology (0); therapeutic use (0)||methods (0)|||etiology (0)||therapeutic use (0)|drug effects (0)
0|0|0|0|0|0|0|0|0|1|0|1|0|0|1|0|0|0|0|0|0|0
null
1979-02-23
2018-11-30
pubmed: 1979-1-1; medline: 1979-1-1 0:1; entrez: 1979-1-1 0:0
pubmed: 31419
Arrhythmias, Cardiac
['Tachycardia']
31,682
1
Myocardial protection during aortic valve replacement. Physiological and metabolic effects of selective coronary perfusion on the fibrillating heart.
MEDLINE
Manual
NLM
The physiological effects and certain aspects of cardiac metabolism were studied in 14 patients undergoing primary aortic valve replacement. The operations were performed under moderate hypothermia (30 degrees +/- 2 degrees C) and blood for coronary perfusion was taken from a sidebranch of the arterial line. The majori...
Scandinavian journal of thoracic and cardiovascular surgery
0036-5580
Print
12
3
Print
1,978
null
null
207-12
V Bomfim (V); L Kaijser (L); C Olin (C)
Journal Article (D016428)
Blood Glucose (Registry: 0, UI: D001786); Lactates (Registry: 0, UI: D007773); Pyruvates (Registry: 0, UI: D011773); Aspartate Aminotransferases (Registry: EC 2.6.1.1, UI: D001219); Alanine Transaminase (Registry: EC 2.6.1.2, UI: D000410)
Adult (UI: D000328, Major: No); Aged (UI: D000368, Major: No); Alanine Transaminase (UI: D000410, Major: No) - Qualifiers: blood (UI: Q000097, Major: No); Aortic Valve (UI: D001021, Major: No) - Qualifiers: surgery (UI: Q000601, Major: Yes); Aortic Valve Insufficiency (UI: D001022, Major: No) - Qualifiers: surgery (UI:...
Adult|Aged|Alanine Transaminase|Aortic Valve|Aortic Valve Insufficiency|Aortic Valve Stenosis|Aspartate Aminotransferases|Blood Glucose|Coronary Circulation|Female|Heart Valve Prosthesis|Heart-Lung Machine|Hemodynamics|Humans|Hydrogen-Ion Concentration|Hypothermia, Induced|Lactates|Male|Middle Aged|Myocardium|Oxygen Co...
||blood (0)|surgery (1)|surgery (0)|surgery (0)|blood (0)|analysis (0)|||||||||blood (0)|||metabolism (1)|||blood (0)||etiology (1)
0|0|0|0|0|0|0|0|1|0|1|0|1|0|0|0|0|0|0|0|0|0|0|0|0
null
1979-02-23
2007-11-15
pubmed: 1978-1-1; medline: 1978-1-1 0:1; entrez: 1978-1-1 0:0
pubmed: 31682
Arrhythmias, Cardiac
['Ventricular Fibrillation']
32,006
1
Labetalol in hypertensive patients with angina pectoris: beneficial effect of combined alpha- and beta-adrenoreceptor blockade.
MEDLINE
Manual
NLM
1. Eight hypertensive patients with angina pectoris had placebo added to their existing medications for 8 weeks, then incremental doses of active labetalol with simultaneous stepwise reduction in other medicines until blood pressure was satisfactorily controlled; after that only labetalol and thiazide (8 weeks) and fin...
Clinical science and molecular medicine. Supplement
0144-4107
Print
4
null
Print
1,978
Dec
null
283s-286s
W F Lubbe (WF); D A White (DA)
Clinical Trial (D016430); Journal Article (D016428)
Adrenergic alpha-Antagonists (Registry: 0, UI: D000317); Adrenergic beta-Antagonists (Registry: 0, UI: D000319); Ethanolamines (Registry: 0, UI: D004983); Labetalol (Registry: R5H8897N95, UI: D007741)
Adrenergic alpha-Antagonists (UI: D000317, Major: No) - Qualifiers: therapeutic use (UI: Q000627, Major: No); Adrenergic beta-Antagonists (UI: D000319, Major: No) - Qualifiers: therapeutic use (UI: Q000627, Major: No); Adult (UI: D000328, Major: No); Aged (UI: D000368, Major: No); Angina Pectoris (UI: D000787, Major: N...
Adrenergic alpha-Antagonists|Adrenergic beta-Antagonists|Adult|Aged|Angina Pectoris|Clinical Trials as Topic|Ethanolamines|Female|Humans|Hypertension|Labetalol|Male|Middle Aged
therapeutic use (0)|therapeutic use (0)|||complications (0); drug therapy (1)||therapeutic use (1)|||complications (0); drug therapy (1)|therapeutic use (1)||
0|0|0|0|0|0|0|0|0|0|0|0|0
null
1979-03-24
2019-10-27
pubmed: 1978-12-1; medline: 1978-12-1 0:1; entrez: 1978-12-1 0:0
pubmed: 32006; doi: 10.1042/cs055283s
Myocardial Ischemia
['Angina Pectoris']
32,009
1
Relation between prognosis and the blood pressure before and during treatment of hypertensive patients.
MEDLINE
Manual
NLM
1. A study was conducted amongst 1247 treated hypertensive patients to determine the predictive power of untreated baseline and achieved treated blood pressures in the development of the complications of hypertension. In addition the relative importance of systolic and diastolic pressures was calculated. 2. Statistical...
Clinical science and molecular medicine. Supplement
0144-4107
Print
4
null
Print
1,978
Dec
null
333s-336s
D G Beevers (DG); J Johnston (J); B L Devine (BL); F G Dunn (FG); H Larkin (H); D M Titterington (DM)
Journal Article (D016428)
Adrenergic beta-Antagonists (Registry: 0, UI: D000319); Benzothiadiazines (Registry: 0, UI: D001581); Diuretics (Registry: 0, UI: D004232); Sodium Chloride Symporter Inhibitors (Registry: 0, UI: D049993)
Adolescent (UI: D000293, Major: No); Adrenergic beta-Antagonists (UI: D000319, Major: No) - Qualifiers: therapeutic use (UI: Q000627, Major: No); Adult (UI: D000328, Major: No); Angina Pectoris (UI: D000787, Major: No) - Qualifiers: etiology (UI: Q000209, Major: No); Benzothiadiazines (UI: D001581, Major: No); Blood Pr...
Adolescent|Adrenergic beta-Antagonists|Adult|Angina Pectoris|Benzothiadiazines|Blood Pressure|Cerebrovascular Disorders|Diuretics|Heart Failure|Humans|Hypertension|Male|Middle Aged|Myocardial Infarction|Prognosis|Sodium Chloride Symporter Inhibitors
|therapeutic use (0)||etiology (0)|||etiology (0)||etiology (0)||complications (0); drug therapy (1); physiopathology (0)|||etiology (0)||therapeutic use (0)
0|0|0|0|0|0|0|0|0|0|0|0|0|0|0|0
null
1979-03-24
2019-10-27
pubmed: 1978-12-1; medline: 1978-12-1 0:1; entrez: 1978-12-1 0:0
pubmed: 32009; doi: 10.1042/cs055333s
Cerebrovascular Disorders
['Cerebrovascular Disorders']